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CHAPTER I 
 
 
INTRODUCTION AND RESEARCH GOALS 
 
Global amphibian declines 
 Major amphibian population declines around the world became an important issue 
among scientists when they met at the First World Congress of Herpetology in 1989.  
Collected data showed that mass die-offs of amphibians began as early as the 1970s in 
several places, including the western United States, Puerto Rico, and northeastern 
Australia (37, 68, 121).  In the late 1980s, more population declines occurred in Central 
America.  As much as 40% of all amphibians disappeared quickly from one site in Costa 
Rica (165).  At the same time, species disappearances were being recorded at other sites 
in Costa Rica, as well as in Ecuador and Venezuela (165, 166, 199, 240).  Many of these 
declines occurred in habitats that were considered to be pristine, with no known 
explanation as to why they happened (37, 68, 121, 165, 166, 199, 240).  As more reports 
of population declines came out in the 1990s, it became clear that amphibian populations 
around the world were in danger (rev. in 4, 40, 107, 210, 213, 231) 
 Approximately 6,300 species of amphibians have been identified (8), and more 
continue to be discovered (9, 125).  As of 2008, nearly 32% of the known species of 
amphibians across the world were classified as threatened or extinct (111, 213).  In 
contrast, 22% of the world‟s mammal species (112) and 12% of the world‟s bird species 
(20) were considered to be threatened or extinct.  Although 38 species of amphibians are 
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known to be extinct, as many as 279 additional species are “possibly extinct” as they 
have not been found in the wild in recent years (111).  Upwards of 42% of all amphibian 
species are experiencing population declines, with the most threatened species residing in 
tropical areas of Central America and the Caribbean Sea (111).  Many of these declines 
had been considered to be enigmatic, although recent research has begun to define the 
causes for this extreme loss of amphibian biodiversity.  The hypotheses that have been 
postulated to explain amphibian population declines include: the introduction of non-
native predators, habitat loss, climate change, increased UV-B radiation, increased 
exposure to contaminants, overuse by humans, and emerging infectious diseases.  
Although any one of these potential causes could lead to amphibian declines, most 
declines are probably due to interacting factors. 
 
Introduction of non-native species 
 The introduction of non-native species can have multiple effects on native 
amphibians.  One effect is the overall decrease of amphibian numbers due to predation.  
A second is the increase of competition between both native and non-native species for 
resources.  Third, non-native species could introduce new pathogens that the native 
species have never encountered.  Lastly, non-native and native species could hybridize, 
which could eventually lead to the loss of both species (51).  The mountain yellow-
legged frog (Rana muscosa) of the Sierra Nevada Mountains has experienced previous 
population declines throughout the 20
th
 century due to the introduction of salmonid fish 
to ponds (124).  Removing the fish from ponds led to the recovery of R. muscosa 
populations, and caging experiments determined that the fish were predatory toward R. 
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muscosa tadpoles (229).  The introduction of mosquitofish and bullfrogs (Rana 
catesbeiana) also led to the decline of the California red-legged frog (Rana aurora 
draytonii), a species classified as threatened (129). 
 
Overall land use change 
 The loss of habitat or breeding sites also plays a role in some amphibian 
population declines.  The reasons for habitat loss are twofold: a change in the way 
humans use land, or a physical conversion from one land type to another (141).  One 
example of habitat loss influencing amphibian population declines came from a study of 
amphibian assemblages in Ontario, Canada.  It concluded that deforestation and wetland 
drainage led to decreased habitat area and less diverse amphibian populations (97).  The 
region studied had once been home to 13 different amphibian species, but most 
communities now consist of green frogs (Rana clamitans), northern leopard frogs (Rana 
pipiens), and American toads (Bufo americanus), suggesting that a change in land use or 
type selects against native species and in favor of those species that are highly adaptable 
to these altered landscapes (51, 98).  In the tropics between 1990 and 1997, 
approximately 60,000 km
2
 of humid tropical forest were converted to agricultural land, 
and approximately 23,000 km
2
 were degraded, each year (1).  The effect of this 
significant land change would have profound effects on amphibian biodiversity and 
population numbers in those areas.  Thus, the loss of habitat either by land use change or 
physical destruction could lead to amphibian population declines as those species unable 
to adapt to the new landscape would die off. 
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Climate change 
 Climate changes, especially increased or decreased overall temperatures and 
changes in total precipitation, may play a role in declining amphibian populations.  
However, it should be noted that it is very hard to establish causality in regards to climate 
change leading to population declines (41).   Some studies have found correlations 
between changes in certain climate factors and population declines.  A study from Brazil 
between 1979 and 1982 hypothesized that severe frost led to the extinction of five 
different frog species (101).  Studies in Australia linked drought conditions to declines of 
stream-dwelling, rain forest species, although an analysis of this data found that the 
correlation between drought and population declines was weak (128).  Drought has also 
been linked to the extinction of montane R. pipiens populations in Colorado (54).  
Research in Costa Rica examining population declines and extinctions of species within 
the genus Atelopus concluded that global warming events, such as increased cloud cover 
and misting, led to higher nighttime temperatures and decreased daytime temperatures.  
This convergence of the mean maximum and mean minimum temperatures would better 
support the growth of B. dendrobatidis (167).  However, this chytrid-thermal-optimum 
hypothesis was challenged by other studies.  One suggested that the epidemics of B. 
dendrobatidis in Costa Rica were better explained by chytrid introduction events and 
subsequent pathogen spread as opposed to more optimal B. dendrobatidis growth 
temperatures (133).  Another report reevaluating the original data determined that the 
temperature convergences were not significant when Atelopus species extinctions were 
increasing, but were significant only when extinctions were decreasing (183).  One 
downside to much of the data linking climate change to amphibian population declines is 
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that the data were obtained over multiple decades, which may have “temporally 
confounded” the results in such a way that any variable that increased over that time 
could be correlated with amphibian losses (183).  A more recent study found that the only 
climate-based population effect on amphibians was an increase in temperature variability, 
which would lead to compromised immune responses and more frequent disease 
outbreaks (184).  Specific evidence that climate change directly causes die-offs is 
lacking, and it is possible that climate change has an indirect effect on amphibian 
communities, such as by disrupting amphibian breeding patterns or by increasing 
susceptibility to infectious diseases (41).  
 
Ultraviolet radiation 
 UV-B radiation is an important stressor in living organisms that can cause 
mutations in organisms and cellular death (21, 49).  Increases of UV-B radiation occur 
after ozone damage, which is due in large part to human-caused release of 
chlorofluorocarbons and other chemicals into the environment (100, 122), though 
transient damage can also be caused by natural disasters (48).  UV-B radiation has 
limited capacity to directly kill developing amphibians, but it may also cause sublethal 
effects including increased embryo mortality, decreased tadpole survival, embryonic 
deformities, reduced growth, and developmental or behavioral abnormalities (21).  UV-B 
radiation may also synergize with other environmental stressors in order to increase the 
incidences of these negative impacts (205).   However, the overall effect of UV-B 
radiation on amphibian mortality in the environment is controversial.  Amphibian 
embryos are well protected from ambient UV-B radiation in their natural environment 
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due to melanin, photolyase, egg jelly, and dissolved organic carbon in the water (131).  
Studies of high-altitude amphibian breeding sites determined that the dissolved organic 
carbon concentrations were sufficient to protect larvae from UV-B radiation (2, 160).  
Studies on embryos from lakes with very little dissolved organic carbon showed no 
significant effect of UV-B radiation on survival after exposure (131).  In laboratory 
settings, egg masses are typically placed much closer to the surface of the water than eggs 
found in nature, which may bias experimental results (131).  Furthermore, the loss of 
some embryos to UV-B exposure would have less impact on populations than losses in 
the post-metamorphic life stages (4, 19, 225).  With no documented mortality in natural 
settings due to UV-B radiation (131), some researchers conclude that there is no link 
between UV-B exposure and amphibian population declines (131, 160), although a 
potential link continues to be studied. 
 
Environmental contaminants 
 Another stressor that could affect the health of organisms is the presence of 
environmental contaminants such as pesticides, herbicides, fertilizers, and other 
pollutants (25, 211).  Pesticides, which were widely used in agriculture to deter pests, can 
induce growth deficiencies, as well as developmental and behavioral abnormalities, in 
frogs that are exposed (21, 34, 211).  Pollution from industries that lead to increased 
heavy metals in the environment or the acidification of water sources can have lethal or 
sublethal effects in amphibians (94, 130).  Acidification of lakes may have contributed to 
local extinctions of the tiger salamander (Ambystoma tigrinum) in Colorado (94).  A 
hypothesis explaining amphibian population declines due to environmental contamination 
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is that contaminants are endocrine disruptors, which leads to malformed reproductive 
systems (211).  This can include the induction of hermaphroditism and demasculanization 
(96) or an increase of corticosterone release that leads to reduced stress responses and 
decreased reproductive performance (81, 104).  One study determined that pesticide drift 
from upwind agricultural land was associated with declines of amphibian species in 
California (59).  UV-B radiation and toxic chemicals can act synergistically, making the 
effect of environmental contaminants on amphibian declines even more complex (20).  
Predatory stressors may also synergize with pesticides, increasing susceptibility of 
amphibians, especially larvae, to death caused by environmental contaminants, although 
this effect tends to only be observed in laboratory settings (171-173). 
 
Emerging infectious diseases 
 Perhaps the best documented reason for the decline of amphibian populations 
around the world is the emergence of infectious diseases in amphibians.  Pathogens have 
been implicated as the cause of many amphibian declines in which no environmental 
disturbance could be linked to die-offs (32, 40, 54).  Emerging diseases in amphibians 
can be divided into two patterns of outbreaks and declines, both typified by a particular 
class of pathogens.  The first pattern is characterized by: 1) deaths restricted to small 
geographic areas; 2) deaths in larval, metamorphosing, or adult individuals; 3) frequent 
outbreaks in areas that are heavily impacted by humans; and 4) infections occurring at 
high population densities (40).  This pattern is largely attributed to outbreaks of 
iridoviruses.  The second pattern is classified by: 1) population declines occurring over a 
wide geographic area; 2) 50-100% mortality rates; 3) greater mortalities at higher 
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elevations or cooler temperatures; 4) susceptibility in only some species present at the 
outbreak site; 5) death largely in adult individuals; and 6) infectious disease as the cause 
of death (40).  This pattern is largely attributed to fungal infections. 
 One particular genus of iridoviruses that has received attention in regards to 
amphibian mass mortalities is the genus Ranavirus.  Ranaviruses are large, double-
stranded DNA viruses with linear genomes that are known to infect amphibians, reptiles, 
and fish (58).  They have been implicated as the cause of mass mortalities seen in the 
United States (66, 86, 88, 117), Venezuela (245), Saskatchewan and Manitoba, Canada 
(24), Australia (55), and the United Kingdom (56).  In the common frog (Rana 
temporaria) in the United Kingdom, ranavirus-induced mortalities were due to either skin 
ulceration or systemic hemorrhage.  Some of the frogs were also infected with an 
opportunistic bacteria (Aeromonas hydrophila), suggesting that death can be caused 
either directly or indirectly by secondary infections (56).  Although ranaviruses are 
capable of inducing mass mortality events in amphibians, there is little evidence that they 
cause species extinctions (58).  However, because ranaviruses induce high infectivity 
across multiple orders and species, as well as the potential for fatal opportunistic 
infections, they are potential agents of die-offs. 
 Growing evidence links a newly emerging fungal pathogen, Batrachochytrium 
dendrobatidis, to amphibian population declines around the world.  This pathogen is 
viewed as the leading cause of enigmatic declines and extinctions, and its characteristics 
and pathogenesis are described in the next section.  
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Batrachochytrium dendrobatidis 
 The amphibian fungal pathogen Batrachochytrium dendrobatidis, initially 
isolated from the blue poison dart frog Dendrobates azureus (135), is classified within 
the phylum Chytridiomycota, a fundamentally basic phylum in the kingdom Fungi (102, 
114, 115).  The Chytridiomycota are described as having motile zoospores that utilize 
one flagellum for movement.  B. dendrobatidis is the only fungus in this phylum that is a 
pathogen of vertebrates (102, 114, 115).  A number of isolates of B. dendrobatidis have 
been collected, but at present there appears to be very little genetic variation among these 
isolates (5 variable nucleotides among 10 loci), suggesting that B. dendrobatidis is a 
newly emergent disease agent (146).  It is not known where B. dendrobatidis originated, 
although Africa, North America, and Asia have been postulated as origin sites (84, 116, 
232).  The life cycle of B. dendrobatidis features two main stages.  The zoospore is the 
infectious particle that disperses into its environment and moves via its flagellum (17, 
135, 228).  The zoospore is motile for only 24 hours before it either encysts or dies.  
Once it reaches a suitable host, the zoospore stops movement, resorbs its flagellum, 
moves into skin cells, and develops into a thallus form with thread-like rhizoids.  The 
thallus further matures into the second main stage, the mature zoosporangium.  Inside the 
zoosporangium, new zoospores develop after cytoplasmic cleavage and the production of 
new flagella.  A capped discharge tube is also produced.  Once the zoosporangium is 
completely mature, the discharge tube cap dissolves and zoospores are released into the 
water to either infect the same individual at a different site on the skin or a second 
individual.  The entire life cycle from zoospore to a mature sporangium releasing new 
zoospores into the environment takes approximately 4 to 5 days at 22°C (17, 228). 
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B. dendrobatidis colonization of the skin 
 B. dendrobatidis colonization occurs in the epidermis of its host.  It may also 
infect the mouthparts of tadpoles, which would become carriers and maintain infection in 
the environment (15, 77, 168).  Once on the surface of the skin, B. dendrobatidis enters 
the epidermal cells of the stratum granulosum and stratum corneum by an unknown 
mechanism (17, 135, 228).  One hypothesis is that the zoospores encyst on the surface of 
the cells then develop a germ tube to inject its genetic material into the cells (17).  
Maturation of the zoospore occurs within these epidermal cells.  It is believed that the 
maturation of B. dendrobatidis in the skin is synchronized with the movement of 
epidermal cells through the skin.  As the infected epidermal cells move from the deeper 
layers of the skin to the superficial layer, the zoospore is maturing into a sporangium and 
producing new zoospores.  Once the epidermal cell becomes superficial, the capped 
discharge tube is produced and oriented toward the outside environment.  The fact that B. 
dendrobatidis maturation is synchronized to epidermal cell movement in the skin 
suggests that the fungus is well adapted to infection of amphibian skin (17, 228). 
 
Chytridiomycosis and B. dendrobatidis pathogenesis 
 An amphibian infected with B. dendrobatidis may develop clinical signs of 
disease or mortality.  The resultant disease caused by B. dendrobatidis infection is termed 
chytridiomycosis.  Signs of chytridiomycosis include: lethargy, abnormal posture, loss of 
appetite and righting reflex, reddening of the skin, and irregular sloughing (226-228).  It 
has been hypothesized that the increase of skin sloughing is due to the amphibian‟s 
attempt to clear the skin of infection, not due to a process initiated by B. dendrobatidis 
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directly (61).  Amphibians with severe infections show high mortality, but exactly how B. 
dendrobatidis kills infected individuals is not well understood.  One potential mechanism 
is the secretion of a toxin or a toxic byproduct that directly kills individuals (15, 162).  A 
second hypothesis, for which evidence is beginning to accumulate, is that B. 
dendrobatidis infection disturbs the skin, disrupting the transport of essential ions or 
water from the environment across the skin (226, 227).  Recent studies of the green tree 
frog (Litoria caerulea) showed that individuals with clinical chytridiomycosis had 
significantly reduced electrolyte transport across the ventral skin.  This in turn led to 
decreased electrolyte concentrations in the blood, especially sodium and potassium 
concentrations, and declining electrical functioning in the heart.  Death eventually 
occurred due to asystolic cardiac arrest (226, 227).  Regardless of the mechanism of 
killing, B. dendrobatidis has the capability of inducing mortality in amphibians, 
especially if the infection intensity is severe. 
 The temperature of the environment may play a role in the overall pathogenesis of 
B. dendrobatidis.  B. dendrobatidis has an optimum temperature range of between 17 - 
23°C, although it can grow at lower temperatures (164, 238).  Temperatures at or above 
30°C are lethal to the fungus (164).  At lower temperatures, such as a range of 7 - 10°C, 
the ability of B. dendrobatidis zoospores to encyst and mature to produce new zoospores 
took a longer period of time.  Although overall growth was slowed at lower temperatures, 
B. dendrobatidis maintained the capacity to grow at a wide range of temperatures (238).  
Temperatures may also play a role in B. dendrobatidis pathogenesis in the wild.  In the 
tropics, amphibian species that had higher prevalences of B. dendrobatidis infection were 
found at lower temperatures (233), and most population die-offs occurred in upland sites 
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that are generally cooler (16).  A hypothesis that climate change is creating more 
optimum temperatures for B. dendrobatidis growth around the world has been postulated 
(167), although this hypothesis is controversial (5, 133, 183, 184).   
 One important aspect of chytridiomycosis is that some species appear resistant to 
B. dendrobatidis whereas others are susceptible.  X. laevis collected and assessed for B. 
dendrobatidis in the field showed no signs of chytridiomycosis, although it was 
determined that the prevalence of B. dendrobatidis was ~3%, a figure that has not 
changed since 1940 (232).  Captive populations of X. laevis also have no apparent clinical 
signs of chytridiomycosis (161).  Experimental infection of X. laevis failed to induce 
chytridiomycosis even when frogs were exposed to very high numbers of zoospores (191 
and this thesis).  There have been no reports of population declines of X. laevis due to B. 
dendrobatidis (232).  In contrast to X. laevis, a frog of the closely related species, 
Silurana (Xenopus) tropicalis, died due to infection with B. dendrobatidis (161). Another 
amphibian, the boreal toad (Bufo boreas), is considered very susceptible to B. 
dendrobatidis both in the wild and in the laboratory.  B. boreas experienced significant 
declines in the southeastern portion of its range between the late 1970s and the early 
1980s (39, 42), as well as in Colorado (151), due to B. dendrobatidis infections.  
Exposure of B. boreas to as little as 10
4
 zoospores for one day experimentally resulted in 
100% mortality (42).  The specific characteristics of each species that determines whether 
they are susceptible or resistant to B. dendrobatidis are unknown, although both innate 
and adaptive immune components may be important in providing resistance in 
amphibians. 
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Research objectives 
 The major hypothesis of my dissertation is that both innate immunity (especially 
antimicrobial peptides) and adaptive immune responses are required for full protection of 
an amphibian species from lethal B. dendrobatidis infections.  A deficiency of one, or 
both, of these systems would increase susceptibility to B. dendrobatidis infections after 
exposure.  In the course of this study, we developed preliminary evidence that B. 
dendrobatidis was able to inhibit the activation of lymphocytes when both cell types were 
co-cultured.  This led to the generation of a second hypothesis; that B. dendrobatidis 
induces hyporesponsiveness in amphibian lymphocytes, which would give it a survival 
advantage once it successfully infects amphibian skin.  The results from studies to 
investigate these hypotheses would help formulate a model of the overall interactions 
between pathogen and the host immune system. 
 The objectives of my dissertation studies are as follows: 
1) To determine whether antimicrobial peptide defenses in a resistant species are 
sufficient to inhibit B. dendrobatidis in vitro.  Previous work in the Rollins-
Smith laboratory and others concluded that there is a correlation between the 
effectiveness of a species‟ antimicrobial peptides in inhibiting the growth of 
B. dendrobatidis in vitro and its survival in the wild or its resistance to 
experimental exposure (234-236).  Thus, it would be likely that a resistant 
species, such as X. laevis, would have very strong antimicrobial peptide 
defenses against B. dendrobatidis.  My work assessed the ability of both 
natural mixtures of X. laevis skin peptides as well as purified individual X. 
laevis peptides to inhibit B. dendrobatidis growth in a growth inhibition assay. 
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2) To evaluate if peptide depletion in a resistant species increases susceptibility 
to B. dendrobatidis after experimental exposure.  In order to test the overall 
role of the antimicrobial peptide defenses in the resistance of X. laevis to B. 
dendrobatidis infection, my work aimed to develop a protocol for depleting 
the skin of its antimicrobial peptide stores.  Once accomplished, frogs would 
be tested for increased susceptibility after both peptide depletion and B. 
dendrobatidis exposure.  Both the intensity of infection on the skin over time 
as well as weight loss would be used as measures of overall susceptibility to 
B. dendrobatidis in peptide depleted and untreated frogs. 
3) To determine if the adaptive immune system is playing a role in protecting a 
resistant species from B. dendrobatidis infection.  Although no laboratory has 
systematically explored the role of adaptive immunity in the protection of 
amphibians against B. dendrobatidis, other studies suggested that adaptive 
immune responses against B. dendrobatidis were poor (15, 162, 175, 200, 
212).  My work was designed to explore the role of adaptive immunity in X. 
laevis after B. dendrobatidis exposure.  We designed experiments to 
determine if inhibiting the adaptive immune system by X-irradiation would 
lead to an increase in susceptibility to B. dendrobatidis in X. laevis.  As 
before, overall susceptibility would be measured both by infection intensity on 
the skin as well as weight loss over time.  We also wanted to examine whether 
a robust adaptive immune response could be generated in X. laevis after 
immunization with B. dendrobatidis as measured by increased B. 
dendrobatidis-specific antibodies in the serum. 
15 
 
4) To identify adaptive immune mechanisms that may protect the skin from B. 
dendrobatidis infections.  Mucus secretions on the surface of amphibian skin 
contain both antimicrobial peptides and lysozyme, an enzyme that can break 
down components of bacterial cell walls (123, 157, 243).  Mammals and fish 
have the ability to secrete antibodies in the mucus (43, 134, 140, 198), but it 
was unknown if amphibian mucus also contains immunoglobulins that could 
help protect the skin.  My work assessed whether mucosal secretions of X. 
laevis contain immunoglobulins and, if so, whether the mucosal antibodies in 
frogs previously exposed to B. dendrobatidis are pathogen-specific. 
5) To assess whether B. dendrobatidis has the capacity to inhibit immunity in 
amphibians after infection.  Several pathogenic fungi, including Cryptococcus 
neoformans (45), Histoplasma capsulatum (6), Aspergillus fumigatus (13, 
215), and Paracoccidioides brasiliensis (38), are able to inhibit lymphocytes 
after infection.  Preliminary work in the Rollins-Smith laboratory suggested 
that B. dendrobatidis inhibited lymphocytes from proliferating in vitro, as 
lymphocytes from immunized X. laevis were unable to become activated and 
proliferate in response to co-culture with B. dendrobatidis (196).  My work 
aimed to elucidate whether B. dendrobatidis could inhibit X. laevis 
lymphocytes after stimulation with mitogens, and characterize the process by 
which activated lymphocytes fail to proliferate when in the presence of B. 
dendrobatidis. 
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CHAPTER II 
 
 
ANTIMICROBIAL PEPTIDE DEFENSES OF XENOPUS LAEVIS AGAINST 
BATRACHOCHYTRIUM DENDROBATIDIS 
 
Abstract 
 Batrachochytrium dendrobatidis is a chytrid fungus that causes the lethal skin 
disease chytridiomycosis in amphibians.  It is regarded as an emerging infectious disease 
affecting diverse amphibian populations in many parts of the world.  Because there are 
few model amphibian species for immunological studies, little is known about immune 
defenses against B. dendrobatidis.  Our work shows that the South African clawed frog, 
Xenopus laevis, is a suitable model for investigating immunity to this pathogen.  
Antimicrobial peptides secreted onto the surface of the skin are known to kill many 
pathogens, including bacteria, viruses, and fungi.  Peptide effectiveness has been 
previously correlated with resistance to B. dendrobatidis infection both in the wild and 
following experimental exposures.  X. laevis is a species considered to be resistant to B. 
dendrobatidis infection, but experiments evaluating the antimicrobial peptide defenses 
against B. dendrobatidis in this species are lacking.  Purified antimicrobial peptides or 
mixtures of peptides in the skin mucus of X. laevis inhibited B. dendrobatidis growth in 
vitro.  Skin peptide secretion was maximally induced by injection of norepinephrine, and 
significant time was required for the recovery of peptide stores after this treatment.  
Maximal induction resulted in sustained skin peptide depletion and increased 
susceptibility to infection.  These data strongly suggest that the antimicrobial peptide 
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defenses in X. laevis constitute a significant barrier to infection, and they play a role in 
resistance to B. dendrobatidis. 
 
Introduction 
 Although studies of innate immunity in X. laevis are limited, this species appears 
to have innate defenses that are similar to other vertebrates (182).  Innate immunity 
includes phagocytic cells such as macrophages, neutrophils, and natural killer cells; 
complement proteins; and the production of lysozyme and antimicrobial peptides within 
the skin mucus.  Although phagocytic cells, complement, and lysozyme may be 
important in the protection of amphibians against infections, including B. dendrobatidis, 
they will not be discussed here.  Antimicrobial peptide defenses on the skin of X. laevis 
are a major part of the work in the Rollins-Smith laboratory, and so my studies were 
focused on these molecules. 
 The dermal layer of the skin of most amphibians contains two different types of 
glands: mucous glands and granular glands (also called poison or serous glands) (29, 142, 
154, 209).  Although mucous glands are important due to their role in producing a 
mucopolysaccharide-rich substance that moistens the skin (75, 85, 202), the granular 
glands play a larger role in innate immunity.  Multiple bioactive peptides, including 
antimicrobial peptides and neuropeptides, are synthesized within the granular glands.  
Antimicrobial peptides in the mucus are thought to protect the amphibian skin by 
eradicating pathogens that attempt to colonize the skin, while neuropeptides act as 
deterrents against predators (11, 52, 57, 76, 153, 179, 208, 242).  The granular gland is 
filled with granules that contain these peptides (67).  Granular glands are surrounded by 
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myoepithelial cells that possess α-adrenoreceptors, and secretion of the contents of the 
glands is stimulated by epinephrine or norepinephrine, which causes the myoepithelial 
cells to contract and push the granules through a duct onto the surface of the skin (14, 67, 
103).  Granular glands are typically found all over the body, though particular glands on 
the dorsal side, such as the ones in the dermal plicae and behind the eyes, are the largest 
(29, 152, 154, 209, 220). 
 The antimicrobial peptides present within the granular glands typically range from 
10 - 50 amino acids in length.  These peptides have activity against a variety of 
pathogens, including gram positive and gram negative bacteria, fungi, protozoa, and 
certain viruses (11, 52, 76, 153, 179, 208, 242).  The sequences of the antimicrobial 
peptides are variable with no consensus amino acid sequence, however most peptides are 
cationic, largely hydrophobic, and can form amphipathic α-helices (239).  The overall 
structure of antimicrobial peptides allows them to disrupt the membranes of pathogens, 
which is thought to be the actual method of killing (11, 52, 153, 179, 208, 242).  Between 
amphibian species there is very little overlap in individual shared peptides, although 
shared families of peptides are common among related species (52). 
 In the Rollins-Smith laboratory, 41 purified antimicrobial peptides from 27 
amphibian species have been tested for their effectiveness in inhibiting the growth of B. 
dendrobatidis in vitro.  About 83% of these peptides inhibited B. dendrobatidis growth at 
minimal inhibitory concentrations (MIC) of 100 µM or less (53, 60, 187-191, 193, 194, 
235).  Natural mixtures of peptides, or the total combination of all peptides secreted from 
granular glands onto the skin, were also tested for their capacity to inhibit B. 
dendrobatidis growth in 24 other species (60, 189, 194, 206, 234-236).  The effectiveness 
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of the peptides in inhibiting B. dendrobatidis growth in vitro correlated with survival 
among groups of species in the wild (234, 235) as well as resistance of some species to B. 
dendrobatidis when experimentally infected (236).  Thus, the antimicrobial peptides 
present in the granular glands of amphibian skin appear to be capable of protecting frogs 
from B. dendrobatidis infection, and the variation in the effectiveness of the peptides 
among species can be used to predict whether a species would be resistant or susceptible 
to B. dendrobatidis (234).  One species not previously studied for antimicrobial peptide 
effectiveness against B. dendrobatidis is X. laevis, a species considered resistant to B. 
dendrobatidis (161, 191, 232).  Although a number of antimicrobial peptides in X. laevis 
have been identified (10, 82, 83, 113, 127, 177, 214, 241), studies of B. dendrobatidis 
growth inhibition by these peptides was lacking.  My work evaluated the growth 
inhibition of B. dendrobatidis by natural mixtures of peptides and purified peptides to 
determine whether these antimicrobial peptide defenses are important in protection of this 
species from lethal B. dendrobatidis infections. 
 
Materials and Methods 
 
Frogs   
 Outbred X. laevis frogs ranging in size from approximately 30 to 50 g were 
purchased from Xenopus I (Dexter, MI) and kept in polystyrene containers at a density of 
about 10 frogs per 16 liters of dechlorinated tap water at a temperature of between 20 to 
24°C.  For the peptide depletion and exposure study, the frogs were young 
postmetamorphic adults ranging in weight from 4 to 5 g.  Three times each week, the 
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frogs were fed ground beef heart and their water was changed.  All procedures involving 
animals were approved by the Vanderbilt University Medical Center Institutional Animal 
Care and Use Committee. 
 
Collection and enrichment of skin peptides 
 Secretion of granular gland contents was stimulated by injection of 
norepinephrine-HCl (Sigma, St. Louis, MO) dissolved in amphibian phosphate buffered 
saline (APBS; 6.6 g NaCl, 1.15 g Na2HPO4, and 0.2 g KH2PO4 per 1 liter distilled water) 
into the dorsal lymph sac.  For resting frogs, individual X. laevis were placed directly into 
collection buffer without norepinephrine stimulation.  Frogs that were given a simulated 
“alarm” stress were removed for their tank, rinsed with clean water, and placed in a 
container filled with 500 ml collection buffer.  The investigator placed a gloved hand into 
the buffer and forced the frogs to swim for 10 minutes before a 5 minute rest period, 
allowing secretions to accumulate in the buffer.  Peptides were partially purified by 
pumping collection buffers through C-18 Sep-paks.  Eluted peptides were quantified by 
microBCA assay, concentrated by centrifugation under vacuum (spin-vac), and 
resuspended in water at a known concentration before use.  Frog weights were 
determined at the time of peptide induction, and total peptide concentrations were divided 
by weight to determine peptide recovery in µg/g.  To estimate the amount of peptides in 
mucus, the surface area of the skin of each frog was calculated according to the method 
of McClanahan and Baldwin [i.e. surface area = 9.9 (weight in grams)
0.56
] (137).  
Assuming the thickness of mucus is 50 µm (36), the volume of mucus covering one cm
2
 
of skin would be 5 µl.  Thus, total peptides (in µg) per cm
2
 x 200 = total µg/ml in mucus. 
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Mass spectrometry 
 To confirm the presence of previously described antimicrobial peptides in the 
samples, enriched skin peptides were analyzed by matrix-assisted laser 
desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) as previously 
described (218, 234). 
 
Growth inhibition assays 
 Growth inhibition of B. dendrobatidis was determined as previously described 
with minor modifications (187, 188, 194).  Briefly, zoospores of B. dendrobatidis isolate 
JEL 197 (135) were isolated after culture for 1 week on 1% tryptone agar at 23°C and 
plated (5 X 10
4
/50 µl, five replicates) in 1% tryptone broth in 96-well flat-bottom 
microtiter plates with or without the addition of 50 µl serial dilutions of a natural mixture 
of skin peptides or individual purified skin peptides from X. laevis dissolved in sterile 
water.  The plates were incubated for 1 week at 23°C.  Positive control wells received 50 
µl of sterile water without peptides.  No growth (negative control) wells contained 
zoospores treated at 60°C for 10 min.  Growth after 7 days was measured as increased 
optical density at 490 nm (OD490) with an MRS Microplate Reader (Dynex Technologies, 
Inc., Chantilly, VA).  Magainin II was purchased from Sigma.  Caerulein precursor 
fragment (CPF) and PGLa (for peptide with amino-terminal glycine and carboxyl-
terminal leucinamide) were a generous gift from Michael Zasloff (Georgetown 
University, Washington DC). 
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Peptide depletion and exposure to B. dendrobatidis 
 Prior to treatment, all frogs were weighed and swabbed for B. dendrobatidis (see 
“Quantification of B. dendrobatidis Zoospores on the Skin” section below) to determine 
initial infection status before being placed in individual sterile containers.  For peptide 
depletion, frogs were injected with 80 nmol/g of norepinephrine via the dorsal lymph sac 
on day -1.  Controls were left untreated, and both groups were exposed to 10
6
 zoospores 
of B. dendrobatidis isolate JEL 197 at day 0 and re-exposed on day 21 with 10
6
 
zoospores of B. dendrobatidis isolate JEL 275.  The switch to JEL 275 was made because 
this isolate is known to be lethal for boreal toads and was isolated from a diseased frog 
more recently.  All frogs were swabbed again on day 32 to quantify B. dendrobatidis 
infection intensity by real-time PCR.  Frog were weighed approximately every 10 days 
throughout the course of this experiment.  All frogs were observed frequently for signs of 
B. dendrobatidis-induced illness.  As a control to determine if norepinephrine injection 
itself affected weight loss, frogs that were PCR-negative for B. dendrobatidis were 
injected with either 80 nmol/g of norepinephrine or with vehicle alone (APBS), and their 
weights were monitored approximately every 10 days for 50 days. 
 
Quantification of B. dendrobatidis zoospores 
 X. laevis frogs were swabbed with a sterile cotton swab 10 times on the abdomen, 
legs, and each foot.  DNA was extracted from swabs by adding 60 µl of PrepMan Ultra 
(Applied Biosystems, Foster City, CA) and 30 to 35 mg zirconium/silica beads (0.5mm 
diameter) (Biospec Products, Bartlesville, OK) to each swab.  Swabs were homogenized 
in a Mini Beadbeater (MP Bio, Solon, OH) for 45 seconds before centrifugation at 15,000 
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x g for 30 seconds.  The homogenization and centrifugation steps were repeated followed 
by boiling the samples for 10 minutes and cooling for 2 minutes at room temperature.  
Samples were centrifuged at 15,000 x g for 3 minutes, and the supernatants containing 
DNA were removed for real-time PCR.  Real-time probe-based PCR assays were 
performed with an Mx3000P Real-Time PCR system (Stratagene, La Jolla, CA) using the 
default conditions (95°C for 10 minutes, followed by 95°C for 30 seconds, 55°C for 1 
minute, and 72°C for 1 minute) for 40 cycles according to standard protocol (30, 110).  A 
standard curve based on the threshold cycle (CT) values from the control zoospore DNA 
was generated, and the number of zoospore equivalents in each sample was calculated. 
 
Statistical comparisons 
 All parameters compared were averaged, and the mean values ± standard error of 
the mean were compared by one-tailed or two-tailed Student‟s t test, one-way analysis of 
variance (ANOVA) with planned comparisons (Tukey post hoc tests), or analysis of 
covariance (ANCOVA) as detailed in the figure legends.  Zoospore equivalents, peptide 
concentrations, and OD values were log transformed as indicated in the figure legends to 
meet the assumptions of normal distribution and homogeneity of variances for parametric 
statistics.  A p value ≤ 0.05 was considered statistically significant.  Error bars shown in 
all figures represent the standard error of the mean, except in Fig. 2-3 E and F, which 
show the 95% confidence intervals.  If no error bar is shown, the standard error of the 
mean was less than the diameter of the symbol.  In B. dendrobatidis growth inhibition 
assays, each data point represents the mean ± standard error of the mean of five replicate 
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wells.  For other parameters, the number of animals or samples is shown in the figure 
legend. 
 
Results 
 
Collection of antimicrobial skin peptides 
 Previous experiments in the Rollins-Smith laboratory showed that X. laevis is a 
species that is resistant to lethal B. dendrobatidis infections (191), and we hypothesized 
that the antimicrobial peptide defenses provide an effective barrier to initial infections by 
B. dendrobatidis.  In order to test this hypothesis, we induced secretion of the 
antimicrobial peptides, determined the pattern of peptides expressed within enriched 
secretions, and utilized both enriched natural mixtures of peptides and purified individual 
peptides in a B. dendrobatidis growth inhibition assay.    
 To determine the pattern of antimicrobial peptide expression in the skin secretions 
of X. laevis, enriched peptide samples were subjected to matrix-assisted laser 
desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry.  Many 
antimicrobial peptides present in X. laevis skin had been previously identified, including 
PGLa (peptide with amino-terminal glycine and carboxyl-terminal leucinamide) (10), 
magainin I and magainin II (241), CPF (caerulein precursor fragment) (82, 83, 113, 177, 
214), LPF (levitide precursor fragment) (113, 127), and XPF (xenopsin precursor 
fragment) (82, 83, 113, 214), and the peptide masses were known.  All X. laevis tested 
routinely contained each of the previously identified antimicrobial peptides.  A 
representative MALDI-TOF profile is shown in Fig. 2-1. 
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Figure 2-1.  MALDI-TOF imaging profile of X. laevis skin secretions after 
induction with 80 nmol/g of norepinephrine.  Previously described antimicrobial 
peptides are labeled, along with their mass-to-charge ratio.  PGLA, peptide with 
amino-terminal glycine and carboxyl-terminal leucinamide; CPF, caerulein precursor 
fragment; XPF, xenopsin precursor fragment; LPF, levitide precursor fragment.  This 
profile is representative of eight individuals. 
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Antimicrobial peptides from X. laevis inhibited the growth of B. dendrobatidis in 
vitro 
 
 The enriched natural mixtures of antimicrobial peptides obtained from X. laevis 
skin were tested for their ability to inhibit the growth of B. dendrobatidis zoospores in 
vitro.  All enriched natural skin peptides mixtures tested strongly inhibited the growth of 
B. dendrobatidis zoospores after one week (Fig. 2-2A and Table 2-1).  There was some 
variability among the samples tested in terms of their inhibitory strength, however all the 
samples inhibited growth at concentrations above 30 to 60 µg/ml.  The MICs, or the 
concentration of peptides needed to abolish all zoospore growth, varied among samples, 
ranging from 62.5 to 500 µg/ml.  At 500 µg/ml the average percent inhibition among the 
samples was 99.4 ± 0.4% (Table 2-1).  The enriched natural peptide samples were also 
tested for their ability to inhibit the growth of mixtures of zoospores and mature 
sporangia.  The peptides also showed strong inhibition of these B. dendrobatidis cells, 
although the MICs were higher compared to zoospores alone (Table 2-2).  These data 
indicated that the peptide mixtures secreted onto the surface of X. laevis skin are potent 
inhibitors of B. dendrobatidis growth, and that they are likely able to prevent initial 
colonization of X. laevis skin after B. dendrobatidis exposure. 
 Three individual purified peptides from X. laevis skin – CPF, PGLa, and magainin 
II – were also tested for their ability to inhibit the growth of B. dendrobatidis zoospores.  
Although natural mixtures of skin peptides were consistently strongly inhibitory, 
previous work in other species of anurans showed that individual peptides differ in 
inhibitory strength (53, 60, 187-191, 193, 194, 235).  The three individual peptides tested 
were strongly inhibitory but possessed different levels of inhibitory activity.  CPF 
inhibited zoospore growth at concentrations above 1.6 µM and had an MIC of 12.5 µM  
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  Figure 2-2.  Antimicrobial peptides from X. laevis skin secretions inhibited B. 
dendrobatidis growth in vitro.  B. dendrobatidis zoospores were cultured in the 
presence or absence of dilutions of (A) natural mixtures of X. laevis skin peptides, (B) 
pure synthetic CPF, (C) pure synthetic PGLa, and (D) pure synthetic magainin II.  
Growth was measured after 7 days as OD490 absorbance.  Positive control denotes B. 
dendrobatidis zoospores grown in broth plus water in the absence of peptides.  
Negative control denotes B. dendrobatidis zoospores that were heat-killed by 
treatment at 60°C for 10 minutes in broth plus water.  MIC = minimum inhibitory 
concentration.  *, Significantly reduced growth compared to the positive control by 
two-tailed Student‟s t-test; p ≤ 0.02. 
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  Table 2-1.  Minimum inhibitory concentrations (MIC) and percent inhibitions of 
growth by natural mixtures of skin peptides tested against B. dendrobatidis 
zoospores. 
* Skin secretions were induced by injection with 80 nmol/g of norepinephrine, 
collected, and processed as described.  Each sample was a single frog. 
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  Table 2-2.  Minimum inhibitory concentrations (MIC) and percent inhibitions of 
growth by natural mixtures of skin peptides tested against B. dendrobatidis whole 
cultures containing both mature sporangia and zoospores. 
* Skin secretions were induced by injection with 80 nmol/g of norepinephrine, 
collected, and processed as described.  Each sample was a single frog. 
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(Fig. 2-2B).  PGLa was able to inhibit growth when concentrations were greater than 25 
µM with an MIC of 50 µM (Fig. 2-2C).  Magainin II was inhibitory at concentrations 
above 32 µM, although it hadn‟t yet reached an MIC at 162 µM (Fig. 2-2D).  We 
interpreted these data to suggest that the antimicrobial peptide milieu present in the skin 
of X. laevis is strongly inhibitory to B. dendrobatidis growth, and the antimicrobial 
peptides potentially protect the frogs from B. dendrobatidis infection by preventing 
colonization. 
 
An “alarm” stress induced the secretion of antimicrobial peptides at physiologically 
relevant concentrations on the skin 
 
 Although the antimicrobial peptide defenses in X. laevis were potent in vitro, the 
frogs must have the capacity to secrete enough antimicrobial peptides on the surface of 
the skin to inhibit colonization.  To determine whether X. laevis individuals were able to 
secrete peptides onto the skin at physiologically relevant concentrations, we determined 
the levels of peptides released in both resting frogs and frogs given an “alarm” stress.  
Resting frogs were only briefly handled as they were removed from their tank and placed 
directly into collection buffer.  After 15 minutes in collection buffer, the frogs were 
removed, and the released peptides were enriched, prepared, and quantified as previously 
described.  Resting frogs released an average concentration of peptides at 3,256 ± 345 
µg/ml in mucus, which is within the range of concentrations required to inhibit B. 
dendrobatidis in vitro (Fig. 2-3A).  Frogs that were given an “alarm” stress were removed 
from their tanks, washed with water, then placed in a separate tank filled with collection 
buffer.  The frogs were chased around the tank by hand, forcing the frog to swim for ten  
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Figure 2-3.  Effects of “alarm” stress of norepinephrine (NE) injection on 
induction of X. laevis skin peptides and recovery of peptide stores in the skin.  (A) 
Effect of simulated predator stress or norepinephrine injection on the secretion of skin 
peptides (n = 5 in each group except 2 nmol/g of NE, n = 3).  *, Significantly greater 
peptide concentration as compared to resting frogs by one-way ANOVA (after log 
transformation) with Tukey post hoc test; p < 0.01.  (B)  Dose-dependent secretion of 
peptides after norepinephrine injection (n = 3 to 5 frogs per dose except 160 nmol/g of 
NE, n = 2).  (C)  Peptide recovery in the skin over time after induction with 80 nmol/g 
of norepinephrine (n = 97 frogs at time 0, 7 to 10 frogs at all other time points).  *, 
Significantly reduced peptide concentration compared to day 0 by one-way ANOVA 
(after log transformation) with Tukey post hoc test; p < 0.05).  (D) Peptide recovery in 
the skin over time after induction with 20 nmol/g of norepinephrine (n = 35 frogs at 
day 0, 4 frogs at day 3, and 10 frogs at other time points).  One outlier value was 
omitted at day 3.  *, Significantly reduced peptide concentration compared to day 0 by 
one-way ANOVA (after log transformation) with Tukey post hoc test; p < 0.01).  (E) 
Peptide recovery in mucus after induction with 80 nmol/g of norepinephrine (mean 
µg/ml ± 95% confidence interval).  Approximately 19,180 µg/ml of peptides remained 
in the mucus after one injection.  Full peptide recovery required approximately 50 to 
105 days.  (F) Peptide recovery in mucus after induction with 20 nmol/g of 
norepinephrine (mean µg/ml ± 95% confidence interval).  Approximately 10,394 
µg/ml of peptides remained in the mucus after one injection.  Full peptide recovery 
occurred by 20.4 days. 
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minutes followed by a five minute rest period.  The frog was removed, and the peptides 
present in the collection buffer were enriched and quantified.  We found that X. laevis 
individuals stressed in this way secreted significantly greater concentrations of peptides 
than resting frogs, having released an average of 19,851 ± 7,340 µg/ml in mucus (Fig. 2-
3A).  We also determined the concentration of peptides released after norepinephrine 
injection.  A minimal dose (0.2 nmol/g) led to the induction of peptides at a level 
equivalent to that seen in resting frogs (2,262 ± 623 µg/ml in mucus).  A higher dose (2 
nmol/g) stimulated secretion of peptide concentrations averaging 41,646 ± 11,121 µg/ml 
in mucus, a level significantly higher than both resting and chased frogs (Fig. 2-3A).  
These data suggested that both resting and stressed frogs were able to release 
concentrations of peptides onto the skin that could inhibit B. dendrobatidis growth.  The 
handling of the resting frogs may be responsible for the induction of peptide secretion, 
but the possibility that resting frogs are able to continuously secrete low levels of 
peptides on their skin to act as an antimicrobial mantle cannot be discounted. 
 
Norepinephrine injection depleted X. laevis skin of its antimicrobial peptides 
 
 Because X. laevis antimicrobial peptides were inhibitory to B. dendrobatidis and 
were secreted at concentrations sufficient for inhibition while resting or after stress, we 
investigated the overall role that these peptides play in the resistance of X. laevis to B. 
dendrobatidis infection.  We developed a protocol for depleting the skin of its peptides, 
and determined whether depletion led to increased susceptibility to B. dendrobatidis 
infection after exposure.  As an initial step in developing this protocol, we determined the 
dose of norepinephrine that stimulated the greatest release of peptides and examined the 
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kinetics of peptide renewal after norepinephrine injection.  Norepinephine injection into 
the dorsal lymph sac led to a dose-dependent increase in peptide secretion, with both 80 
nmol/g and 160 nmol/g inducing concentrations of peptides that were maximal and not 
significantly different (Fig. 2-3B).  Thus, we considered 80 nmol/g the dose sufficient for 
maximal peptide secretion.  To examine the kinetics of peptide renewal following 
norepinephrine injection, groups of frogs were initially given either the maximal dose (80 
nmol/g) or a moderate dose (20 nmol/g) of norepinephrine.  Over time a subset of frogs 
from each group was injected again with the same dose, and the concentration of peptides 
recovered was determined.  At both one and three weeks after the initial induction with 
80 nmol/g of norepinephrine the concentrations of peptides released were significantly 
reduced.  By seven to nine weeks the peptide levels were still slightly decreased as 
compared to the initial concentration secreted, but this difference was no longer 
significant (Fig. 2-3C).  When the data were analyzed by determining the slope of 
recovery, we calculated that frogs retained the ability to secrete approximately 19,180 µg 
of peptides/ml in mucus after the initial injection, and that full recovery of peptide stores 
in the skin would require between 50 and 104 days (Fig. 2-3E).  In comparison to the 
maximal dose, the concentration of peptides recovered three days after initial stimulation 
with a moderate dose (20 nmol/g) of norepinephrine was significantly reduced, but full 
recovery occurred by four to five weeks (Fig. 2-3D).  Analyzing the data by evaluating 
the slope of recovery showed that after that first injection with 20 nmol/g of 
norepinephrine frogs could still secrete approximately 10,394 µg of peptides/ml in 
mucus, and full recovery required around 20 days (Fig. 2-3F).  These data indicated that 
induction of peptide secretion with 80 nmol/g of norepinephrine reduced the 
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concentration of peptides that remained available for secretion, and that the kinetics of 
peptide renewal were very slow.  Thus, we determined that 80 nmol/g of norepinephrine 
was an appropriate dose for depleting the skin of its peptide defenses, allowing us to 
examine the importance of this defense in the protection of X. laevis from B. 
dendrobatidis infection. 
 
X. laevis depleted of their antimicrobial skin peptides were more susceptible to B. 
dendrobatidis 
 
 To determine the infection intensity of B. dendrobatidis on the skin of exposed 
frogs, we swabbed the skin of each individual with sterile cotton swabs (30, 110).  To 
evaluate the protection afforded by the antimicrobial peptides present in the skin, a group 
of frogs was injected with 80 nmol/g of norepinephrine in order to deplete peptide stores 
one day prior to exposure to 10
6
 B. dendrobatidis zoospores of isolate JEL 197 (135).  
Control frogs were not treated, but were exposed to B. dendrobatidis at the same 
infectious dose.  Both groups were exposed to B. dendrobatidis isolate JEL 275 (179) 21 
days after the first exposure.  At 32 days after the first exposure, all frogs were swabbed 
to determine the infection intensity on the skin.  The intensity of infection was 
significantly greater in frogs that were injected with 80 nmol/g of norepinephrine to 
deplete the skin peptides compared to frogs that were untreated and exposed (Fig. 2-4A).  
The increase in infection intensity after peptide depletion indicated that the loss of 
antimicrobial peptide defenses rendered the frogs more susceptible to B. dendrobatidis 
infection.  As a second measure of increased susceptibility after peptide depletion, we 
monitored weight changes in both the norepinephrine-injected and untreated B. 
dendrobatidis-exposed groups.  The peptide-depleted frogs lost significantly more weight  
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  Figure 2-4.  Peptide depletion induced by norepinephrine increased susceptibility 
of X. laevis to B. dendrobatidis.  (A) Intensity of infection on the skin of frogs that 
were either untreated (n = 10) or injected with 80 nmol/g of norepinephrine (peptide-
depleted) (n = 10) on day -1.  Both groups were exposed to B. dendrobatidis 
zoospores on days 0 and 21, and the infection intensity was measured on day 32 by 
real-time PCR.  The data represents the mean log zoospore equivalents + 1 ± SEM.  *, 
Significantly greater number of zoospore equivalents present on the skin as compared 
to untreated frogs by one-tailed Student‟s t test (after log transformation); p = 0.0395.  
(B) Percentage of initial weight over time in untreated or peptide-depleted frogs 
exposed to B. dendrobatidis.  Treatments were significantly different by ANCOVA; p 
= 0.028.  *, Significantly increased percentage of weight loss compared to untreated 
frogs by two-tailed Student‟s t test; p ≤ 0.05.  (C) Percentage of initial weight over 
time in APBS-injected or norepinephrine-injected (80 nmol/g) frogs left unexposed to 
B. dendrobatidis.  Treatments were significantly different by ANCOVA; p < 0.001.  *, 
Significantly increased percentage of weight loss compared to APBS-injected frogs by 
two-tailed Student‟s t test; p = 0.0077.  Lines connect data points for ease of 
interpretation only. 
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compared to the untreated control frogs as determined by ANCOVA (p = 0.028).  
Significantly greater weight loss in peptide-depleted frogs was observed up to three 
weeks after exposure as compared to untreated frogs (Fig. 2-4B).  These data further 
suggested that peptide depletion resulted in X. laevis that were more susceptible to B. 
dendrobatidis.  It is possible that the injection of the high dose of norepinephrine alone 
could have caused the weight loss instead of B. dendrobatidis infection.  Therefore, with 
the help of an undergraduate, Laura Harper, we tested the effect of norepinephrine 
injection on weight loss in individuals that tested negative for an existing B. 
dendrobatidis infection.  One group of X. laevis individuals was injected with 80 nmol/g 
of norepinephrine, while a second group was injected with amphibian phosphate buffered 
saline (APBS) as a control.  Both groups were left unexposed, and weight loss was 
measured over time.  Although both groups differed significantly by ANCOVA (p < 
0.001), norepinephrine-injected frogs only showed significant weight losses at day 4 
when compared to APBS-injected controls (Fig. 2-4C).  This suggested that 
norepinephrine injection led to temporary weight loss.  Thus, B. dendrobatidis is more 
likely to be the cause of the sustained weight loss seen in peptide-depleted and exposed 
frogs.  These results were clear evidence that antimicrobial peptides present in mucosal 
secretions play a major role in limiting the degree of B. dendrobatidis infection on the 
skin. 
 
Discussion 
 This study was the first to systematically explore the immune defenses of a model 
amphibian, X. laevis, against the emerging infectious fungal pathogen, B. dendrobatidis.  
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Because B. dendrobatidis is a skin pathogen, understanding the immune defenses that are 
present in the skin is critical for determining the characteristics of disease resistance 
versus susceptibility.  The data from this chapter strongly suggest that innate immune 
defenses, in particular antimicrobial peptides, are involved in the resistance to lethal B. 
dendrobatidis infections in X. laevis. 
 Antimicrobial peptides secreted by the skin mucus constitute one of the most 
important innate immune defenses in amphibian skin.  Many studies have demonstrated 
that the skin peptides from various amphibian species can inhibit the growth of B. 
dendrobatidis in vitro (53, 187-195, 234-236).  In this study, we show that the peptides 
present in skin secretions of X. laevis are also able to strongly inhibit B. dendrobatidis 
zoospore growth.  The most active purified peptide, CPF, had an MIC of 12.5 µM, while 
enriched mixtures of skin peptides had MICs that ranged from 62.5 to 500 µM when 
tested against zoospores (Fig. 2-2 and Table 2-1).  In the life cycle of B. dendrobatidis, 
the zoospore is the infectious stage, and it is responsible for establishing infection on the 
surface of amphibian skin.  Once on the skin, the zoospore colonizes epithelial cells, 
where it further matures and replicates (15, 17, 135, 162).  Antimicrobial peptides have 
the capability of preventing the initial infection and colonization of epithelial cells by 
killing zoospores in the mucus.  By constantly secreting small concentrations of 
antimicrobial peptides onto the skin, frogs can inhibit reinfection of the skin by newly 
emerging zoospores in an established infection.  Frogs that were placed under stress that 
mimicked predator attack secreted significantly increased amounts of skin peptides than 
resting, unmanipulated frogs (Fig. 2-3A).  However, both groups secreted amounts of 
peptides that were within the range of concentrations necessary to inhibit zoospore 
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growth (Fig. 2-2A).  These data indicate that frogs that are exposed to B. dendrobatidis in 
the wild can secrete skin peptides at concentrations that could prevent initial infections.  
To put this in perspective, previous studies with stream-dwelling Australian amphibian 
species have shown that there was a correlation between the effectiveness of skin 
peptides in inhibiting B. dendrobatidis growth in vitro and population declines.  Those 
species with the greatest peptide effectiveness did not decline, while those with the 
poorest effectiveness did (235).  This was recapitulated in the laboratory, where species 
with the greatest in vitro peptide effectiveness showed significantly better survival after 
experimental exposure to B. dendrobatidis (236).  The ability to predict the susceptibility 
of a species to B. dendrobatidis based on antimicrobial peptide effectiveness may be 
useful in conservation efforts.  A study of stream-dwelling amphibians in Panama 
suggested that two out of the nine species tested would be predicted to experience 
population declines after B. dendrobatidis exposure due to their weak peptide 
effectiveness (234). 
 The peptide stores in the skin of amphibians require time to recover after they are 
secreted onto the skin surface.  The Rollins-Smith lab previously determined that X. 
laevis injected with the maximal dose of norepinephrine (80 nmol/g) had not fully 
recovered their peptides after 3 weeks (193).  The data from this study suggest that 
peptide levels had recovered by 7 to 9 weeks (Fig. 2-3C).  Analysis of the slope of 
recovery further suggested that 50 to 104 days were required for complete peptide 
recovery (Fig. 2-3E).  After a more moderate dose of norepinephrine (20 nmol/g), about 4 
weeks are necessary for the recovery of peptides in the skin of X. laevis (Fig. 2-3D), and 
these animals would be expected to have full peptide stores within 20.4 days (Fig. 2-3F).  
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Thus, induction of skin peptide release using the maximal dose of norepinephrine would 
allow for peptide depletion lasting for several weeks.  After depletion with 80 nmol/g of 
norepinephrine, exposure of X. laevis to B. dendrobatidis resulted in a significantly 
higher intensity of infection compared to untreated and exposed control frogs at day 31 
after first exposure (Fig. 2-4A).  Peptide-depleted frogs also lost significantly more 
weight than the controls (Fig. 2-4B).  This weight loss was not due to the norepinephrine 
itself (Fig. 2-4C), suggesting that frogs were losing weight due to the effects of B. 
dendrobatidis.  B. dendrobatidis exposure in more susceptible species, such as 
Pseudacris triseriata (174) and Rana muscosa (93), also resulted in significant weight 
losses.  This is the clearest evidence that antimicrobial peptide defenses play a role in 
limiting B. dendrobatidis infection on the skin.  It is possible that norepinephrine 
injection could be causing other immunosuppressive effects, such as corticosterone 
release (207), but the most direct effect of injection was the depletion of peptides stores 
in the skin.  
 Future studies will be designed to investigate whether one injection of 
norepinephrine at the maximal dose is sufficient to cause complete depletion.  After 
injection with norepinephrine, frogs still retain the ability to secrete concentrations of 
peptides that are within the range of concentrations needed to inhibit B. dendrobatidis 
growth (Figs. 2-3E and F).  Recent histological studies in the Rollins-Smith lab have 
suggested that more than one injection with 80 nmol/g of norepinephrine may be 
necessary to completely deplete the skin of its peptides.   
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CHAPTER III 
 
 
ADAPTIVE IMMUNE DEFENSES OF XENOPUS LAEVIS AGAINST 
BATRACHOCHYTRIUM DENDROBATIDIS 
 
Abstract 
 Batrachochytrium dendrobatidis is a chytrid fungus that causes the lethal skin 
disease chytridiomycosis in amphibians.  It is regarded as an emerging infectious disease 
affecting diverse amphibian populations in many parts of the world.  Because there are 
few model amphibian species for immunological studies, little is known about immune 
defenses against B. dendrobatidis.  The studies described in this chapter show that the 
South African clawed frog, Xenopus laevis, is a suitable model for investigating 
immunity to this pathogen.  After an experimental exposure, a mild infection developed 
over 20 to 30 days and declined by 45 days postexposure.  Sublethal X-irradiation of 
frogs decreased leukocyte numbers in the spleen and resulted in greater susceptibility to 
infection.  Immunization against B. dendrobatidis induced elevated pathogen-specific 
IgM and IgY serum antibodies.  Mucus secretions from X. laevis previously exposed to 
B. dendrobatidis contained significant amounts of IgM, IgY, and IgX antibodies that bind 
to B. dendrobatidis.  These data strongly suggest that adaptive immune defenses are 
involved in the resistance of X. laevis to lethal B. dendrobatidis infections. 
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Introduction 
 X. laevis is used as a model to study adaptive immunity in amphibians, and as a 
result, much is known about the cells, tissues, and molecules that play a role in adaptive 
immunity (40, 72, 182).  In general, amphibian adaptive immunity is fundamentally 
similar to mammals, although some features of the adaptive immune system are lacking.  
One major difference between mammalian and amphibian adaptive immune systems is 
that amphibians lack lymph nodes (136).  In amphibians, the major secondary organ in 
which adaptive immunity develops is the spleen (136).  Another difference is that bone 
marrow, which is absent from some species, is responsible for developing granulocytes 
but not lymphocytes in X. laevis.  Instead, B lymphocytes and other hematopoietic cells 
develop in the spleen and liver (T lymphocytes develop in the thymus) (91).  However, 
the remaining aspects of amphibian adaptive immunity, including cell types, complement 
proteins, cytokines, and chemokines are very similar to the mammalian adaptive immune 
system. 
 In X. laevis there are three main isotypes of immunoglobulin heavy chains (74): 
IgM (90, 203, 204), IgY (7, 150), and IgX (109, 149).  The gene for IgD, which is 
homologous to fish IgW, has been recently identified (156).  A fifth isotype, IgF, has 
been characterized in Silurana (Xenopus) tropicalis (244).  IgM, a polymeric 
immunoglobulin, is the first isotype to develop during ontogeny, as well as the first 
produced after experimental immunization (74).  The second isotype, IgY, is generated 
shortly after IgM.  IgY is considered the amphibian equivalent of IgG, and develops after 
T cell-dependent class switch recombination (74).  IgX, a polymeric (hexamer) 
immunoglobulin analogous to IgA, is found largely in the gut and plays a role in the 
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defense of the digestive tract and other mucosal surfaces (109, 149).  It is known that 
immunoglobulins can be secreted in mucus in mammals and fish (43, 134, 140, 198), but 
the ability of amphibians to release antibodies via mucosal secretions has not been 
determined. 
 T cell-mediated responses are also critical for the production of effective adaptive 
immune responses in amphibians.  Thymectomy studies show that T cells play a role in 
skin graft rejection, mixed lymphocyte reactions, and responses to the T cell mitogens 
phytohemagglutinin (PHA) and concanavalin A (ConA) (71, 89, 105, 178, 219).  Much is 
known about T cell-mediated responses as a result of studies of skin graft rejection.  
Major histocompatibility complex (MHC) or minor histocompatibility antigens are 
required for graft rejection, and this rejection is illustrated by classical first- and second-
set kinetics (12, 44, 50, 64, 65, 69, 70, 155).  Previous work shows that both cytotoxic 
and helper T cell responses are MHC-restricted (23, 78, 95).  The role of CD8
+
 cells in 
graft rejection and viral immunity has also been characterized (145, 181).  The T cell 
receptor (TCR)-α and -β genes, as well as the less common TCR-γ and -δ genes, have 
been described (47, 92, 170).  In X. laevis, the distribution of α/β and γ/δ cells is 
unknown, although reagents directed against conserved regions of γ/δ TCRs stained cells 
in the skin, suggesting that γ/δ T cells may play a role in skin immunity (139).   
 Very little is known about the potential adaptive immune responses in amphibians 
after B. dendrobatidis infection.  The prevailing view before these studies were 
undertaken is that adaptive immune responses do not play a role in protecting amphibians 
from chytridiomycosis.  Previous studies show limited lymphocytic infiltrate in 
histological skin sections of exposed frogs (15, 162).  Furthermore, immunization of 
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Rana muscosa juveniles with formalin-killed B. dendrobatidis cells did not protect the 
frogs from developing chytridiomycosis after exposure to live B. dendrobatidis (212).  
During the course of our work, two microarray studies were published that found little 
evidence of the initiation of adaptive immune responses after B. dendrobatidis infection 
in S. tropicalis (175, 200).  Nevertheless, systematic studies of adaptive immunity in the 
protection of amphibians against B. dendrobatidis are lacking, and my work focused on 
determining whether adaptive immune responses could be generated against B. 
dendrobatidis and whether adaptive immunity plays a role in protection. 
 
Materials and Methods 
 
Frogs 
 Outbred X. laevis frogs ranging in size from approximately 30 to 50 g were 
purchased from Xenopus I (Dexter, MI) and kept in polystyrene containers at a density of 
about 10 frogs per 16 liters of dechlorinated tap water at a temperature of between 20 to 
24°C.  Three times each week, the frogs were fed ground beef heart and their water was 
changed.  All procedures involving animals were approved by the Vanderbilt University 
Medical Center Institutional Animal Care and Use Committee. 
  
Collection of mucus secretions 
 X. laevis frogs that were previously exposed to B. dendrobatidis approximately 5 
months earlier were injected with 80 nmol/g of norepinephrine and placed in 50 ml of 
collection buffer for 15 minutes.  Buffers were immediately frozen on dry ice, then 
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lyophilized and resuspended in lysis buffer (8.77 g NaCl, 1.68 g EDTA, 1.58 g Tris-Cl, 
and 10 ml Triton X-100 per 1 liter of distilled water, supplemented with 1 ml each of 5 
mM dithiothreitol, 100 µM phenylmethylsulfonyl fluoride in isopropanol, and 5 mM ε-
aminocaproic acid).  Sample concentrations were assessed by microBCA assay 
performed according to manufacturer‟s instructions.  The presence of each 
immunoglobulin class, the total concentration of each class, and the relative amounts of 
antibodies binding to B. dendrobatidis were determined by ELISA as described below. 
 
Irradiation and exposure to B. dendrobatidis 
 Prior to treatment, all frogs were weighed and swabbed for B. dendrobatidis (see 
“Quantification of B. dendrobatidis zoospores” section below) to determine initial 
infection status before being placed in individual sterile containers.  Frogs were subjected 
to irradiation with 9 Gy X-rays or injected with 80 nmol/g of norepinephrine and also 
irradiated with 9 Gy X-rays on day -1 (a third group was also peptide depleted without 
irradiation; see Chapter 2).  Control frogs were left untreated, and all groups were 
exposed to 10
6
 JEL 275 zoospores in 500 ml water supplemented with 0.005 IU/ml 
penicillin and 0.005 µg/ml streptomycin at days 0 and 21.  Each frog was swabbed for B. 
dendrobatidis and weighed approximately every 10 days.  Infection intensity was 
determined by real-time PCR.  All frogs were observed frequently for signs of B. 
dendrobatidis-induced illness. 
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Effects of irradiation on leukocytes and on peptide secretion 
 Frogs were either irradiated with 9 Gy X-rays or left untreated, and the spleens 
were removed 5 days later.  Total leukocytes were enriched over Ficoll, counted, and 
expressed as total leukocytes per gram of body weight.  Skin squares from both groups 
were fixed in 10% formalin and stained by H&E staining.  In a second experiment, frogs 
were either irradiated with 9 Gy X-rays or left untreated, injected with 2 nmol/g of 
norepinephrine at 3 or 10 days after treatment, and placed in collection buffer for 15 
minutes to collect and quantify peptides as described in Chapter 2. 
 
Quantification of B. dendrobatidis zoospores 
 X. laevis frogs were swabbed with a sterile cotton swab 10 times on the abdomen, 
legs, and each foot.  DNA was extracted from swabs by adding 60 µl of PrepMan Ultra 
(Applied Biosystems, Foster City, CA) and 30 to 35 mg zirconium/silica beads (0.5mm 
diameter) (Biospec Products, Bartlesville, OK) to each swab.  Swabs were homogenized 
in a Mini Beadbeater (MP Bio, Solon, OH) for 45 seconds before centrifugation at 15,000 
x g for 30 seconds.  The homogenization and centrifugation steps were repeated followed 
by boiling the samples for 10 minutes and cooling for 2 minutes at room temperature.  
Samples were centrifuged at 15,000 x g for 3 minutes, and the supernatants containing 
DNA were removed for real-time PCR.  Real-time probe-based PCR assays were 
performed with an Mx3000P Real-Time PCR system (Stratagene, La Jolla, CA) using the 
default conditions (95°C for 10 minutes, followed by 95°C for 30 seconds, 55°C for 1 
minute, and 72°C for 1 minute) for 40 cycles according to established protocols (30, 
110).  A standard curve based on the threshold cycle (CT) values from the control 
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zoospore DNA was generated, and the number of zoospore equivalents in each sample 
was calculated. 
 
Immunization and blood collection 
 Prior to immunization, 20 X. laevis individuals were anesthetized, and blood was 
drawn by cardiac puncture to obtain pre-immune plasma samples.  Immunized frogs were 
injected intraperitoneally (10 µl per gram body weight) with 5 x 10
7
 heat-killed (60°C for 
20 minutes) JEL 197 whole culture cells (mature sporangia and zoospores) at days -42,  
-28, and -0 prior to the collection of serum samples.  Control frogs were injected with 
vehicle (APBS) alone (10 µl per gram body weight).  Frogs were anesthetized, blood was 
drawn by cardiac puncture on days 7, 14, 21, and 28 after the final immunization, and 
IgM and IgY antibodies that bind B. dendrobatidis were quantified by ELISA (see 
“ELISA” section below).  B. dendrobatidis-specific IgY titers in sera from APBS-
injected or B. dendrobatidis-immunized frogs were also determined by ELISA (see 
“ELISA” section below). 
 
ELISA 
 B. dendrobatidis antigen-coated 96-well plates were prepared by adding 5 x 10
4
 
JEL 197 cells at 50 µl per well as either zoospores alone or as whole cultures (mature 
sporangia and zoospores).  Plates were centrifuged at approximately 200 x g, and the 
cells were fixed by the addition of 0.25% glutaraldehyde in APBS.  Fixative was 
removed, and the plates were washed with APBS supplemented with 0.5% bovine serum 
albumin and 0.1% Tween-20 (ABT) and stored at 4°C.  X. laevis sera (1/100 dilution) or 
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lyophilized mucus (at 1 mg/ml) in ABT were added to the wells, and B. dendrobatidis-
specific antibodies were detected using anti-Xenopus monoclonal antibodies specific for 
IgM (10A9), IgY (11D5) (108), or IgX (410D9) (149), followed by horseradish 
peroxidase-conjugated goat anti-mouse antibodies.  Reactions were visualized with 3, 3‟, 
5, 5‟-tetramethylbenzidine substrate.  After about 60 minutes, the reaction was stopped 
by the addition of 2 M H2SO4, and the plates were read at 450 nm (OD450) in an ELISA 
plate reader. 
 To test for the presence of total IgM, IgY, or IgX in mucosal secretions, 
lyophilized mucus samples were diluted to a concentration of 5 mg/ml in ABT and plated 
in a 96-well microtiter plates (4 replicates).  Plates were incubated at 37°C for 1 hour.  
Control wells were coated with 1% normal rabbit serum in ABT.  After incubation, all of 
the wells were blocked with 1% BSA in ABT at 37°C for 2 hours.  The plates were 
washed with ABT, and IgM, IgY, and IgX were detected using antibodies specific for 
IgM (10A9), IgY (11D5) (108), or IgX (410D9) (149), followed by horseradish 
peroxidase-conjugated goat anti-mouse antibodies.  Reactions were visualized by the 
addition of substrate as described above.  Using purified IgM, IgY, and IgX standards, a 
standard curve was generated, and total antibodies of each class were quantified. 
 
Statistical comparisons 
 All parameters compared were averaged, and the mean values ± standard error of 
the mean were compared by one-tailed or two-tailed Student‟s t test, one-way analysis of 
variance (ANOVA) with planned comparisons (Tukey post hoc tests), or analysis of 
covariance (ANCOVA) as detailed in the figure legends.  Zoospore equivalents, peptide 
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concentrations, and OD values were log transformed as indicated in the figure legends to 
meet the assumptions of normal distribution and homogeneity of variances for parametric 
statistics.  A p value ≤ 0.05 was considered statistically significant.  Error bars shown in 
all figures represent the standard error of the mean.  If no error bar is shown, the standard 
error of the mean was less than the diameter of the symbol.  For all parameters, the 
number of animals or samples is shown in the figure legend. 
 
Results 
 
Natural kinetics of B. dendrobatidis infection over time 
To determine whether adaptive immunity played a role in protection of a resistant species 
such as X. laevis from B. dendrobatidis infection, we first examined the kinetics of 
infection in a naïve frog.  Naïve individuals were exposed to B. dendrobatidis isolate JEL 
275 at two time points (days 0 and 21), and infection intensity on the skin was monitored 
over 60 days.  All X. laevis individuals used in this protocol tested negative for B. 
dendrobatidis prior to the first exposure.  After exposure, 90% of the exposed frogs tested 
positive for low level infection of B. dendrobatidis on day 11, with an average infection 
intensity of 7.4 ± 3.4 zoospore equivalents.  The intensity of infection increased 
significantly to 272.5 ± 124.2 zoospore equivalents by day 20.  Day 30 did not 
significantly differ from day 20, but by day 44 the infection intensity had decreased to a 
low of 5.2 ± 1.7 zoospore equivalents (Fig. 3-1A, no treatment group).  These data 
suggested that immune defenses in naïve frogs were activated within 30 days after 
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  Figure 3-1.  X-irradiation increased susceptibility to B. dendrobatidis infections in 
X. laevis.  (A) Intensity of infection on the skin of frogs treated as listed in the figure 
legend before exposure to B. dendrobatidis zoospores on days 0 and 21.  Intensities 
were measured by real-time PCR on days 0, 11, 20, 30, 44, and 59.  The X-irradiated 
frogs both with or without peptide depletion by injection with 80 nmol/g of 
norepinephrine had significantly higher infection intensities as compared to untreated 
and exposed frogs by ANCOVA (p < 0.001).  In this experiment, peptide depletion 
alone did not lead to increased infection intensity after exposure.  Each data point 
represents the mean log zoospore equivalents + 1 ± SEM (n = 8 to 10 frogs).  (B & C) 
Percentage of initial weight over time in frogs that were (B) not irradiated but exposed 
to B. dendrobatidis, X-irradiated and left unexposed, X-irradiated and exposed; or (C) 
not irradiated but exposed and peptide depleted plus X-irradiated and exposed.  The 
change in weight over time differed significantly over time by ANCOVA (p < 0.001).  
*, Significantly greater weight loss compared to not irradiated and exposed frogs by 
two-tailed Student‟s t test for each time point (p ≤ 0.05).  The data for panels B & C 
were pooled from two similar experiments (n = 19 or 20 per group).  Lines connect 
data points for ease of interpretation only. 
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infection, and that they were able to control B. dendrobatidis infections within 45 days of 
exposure. 
 
Effects of X-irradiation on susceptibility to B. dendrobatidis infection 
 One way to suppress the adaptive immune system in vertebrates is to irradiate 
with either X-rays or gamma-rays, which destroys the lymphoid cells in the body.  A 
group of X. laevis individuals was irradiated with a sublethal dose of X-rays (9 Gy) one 
day before exposure to B. dendrobatidis isolate JEL 275.  As before, the irradiated frogs 
were exposed a second time at day 21, and infection intensity was measured over time by 
real-time PCR.  The intensities of infection in the irradiated and B. dendrobatidis-
exposed frogs were significantly greater in comparison to those of nonirradiated and 
exposed controls (ANCOVA, p ≤ 0.001).  There was a two-log increase in infection 
intensity after X-irradiation at day 20 and a one-log increase at day 30.  Like the control 
group, the infection intensity declined by day 44 in the irradiated frogs (Fig. 3-1A).  As a 
measure of morbidity to B. dendrobatidis infection, weight changes in both the irradiated 
and nonirradiated groups were monitored over the course of the experiment after 
exposure.  Those frogs that were irradiated and exposed to B. dendrobatidis experienced 
much greater weight loss over time than the group that was nonirradiated and exposed 
(ANCOVA, p < 0.001).  The weight loss was not attributed to the X-ray irradiation, as a 
group of frogs that was irradiated but not exposed maintained their weight throughout the 
time course of this experiment (Fig. 3-1B).  These data demonstrated that suppression of 
the adaptive immune system via X-irradiation resulted in greater susceptibility of X. 
51 
 
laevis to B. dendrobatidis infection.  This was the clearest evidence that adaptive 
immunity plays a role in the protection of a resistant species from B. dendrobatidis. 
 We also evaluated a group of frogs that were both X-irradiated and peptide-
depleted by injection with 80 nmol/g of norepinephrine before exposure to determine if 
the loss of both innate and adaptive defenses would lead to a further increase of infection 
intensity on the skin.  These doubly-treated frogs displayed infection intensity kinetics 
similar to those seen with frogs that were irradiated and exposed to B. dendrobatidis (Fig. 
3-1A).  The peptide-depleted and irradiated frogs also lost significantly more weight 
compared to controls (Fig. 3-1C).  Both the increased infection intensity and weight loss 
suggested that frogs that were irradiated and peptide-depleted were more susceptible to B. 
dendrobatidis infection than controls, though not more so than frogs that were only 
irradiated and exposed.  In this experiment, we also tested frogs that were peptide-
depleted only before exposure, and those frogs did not show an increase in susceptibility 
after exposure (Fig. 3-1A).  Nevertheless, both innate and adaptive immune responses 
appear to be involved in the protection of X. laevis against B. dendrobatidis infections. 
 
Effects of X-irradiation on splenic leukocytes and skin peptide secretion 
 
 To determine whether the irradiation protocol affected adaptive immune cells, we 
removed the spleens from a group of irradiated frogs, quantified the total number of 
leukocytes isolated, and compared the numbers to those of frogs that were not irradiated.  
X-ray irradiation led to a significantly decreased number of leukocytes that could be 
isolated from the spleen (Fig. 3-2A), suggesting that the sublethal dose of X-rays severely 
impacted the frog‟s ability to mount an adaptive response.  Irradiation of animals can  
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Figure 3-2.  X-ray irradiation reduced leukocyte numbers in the spleen but did 
not damage the skin nor alter the capacity to secrete skin peptides.  (A) Effects of 
X-irradiation (9 Gy) on total leukocyte numbers in the spleen 5 days after treatment (n 
= 3 for each treatment).  *, Significantly reduced numbers of leukocytes as compared 
to untreated controls by two-tailed Student‟s t test (p = 0.0314).  (B) Dorsal skin 
sections stained by H&E staining.  The epidermal cells look healthy and intact, 
regardless of treatment status.  Granular glands are also healthy and remain filled with 
granules.  (C) Effects of X-irradiation on capacity to secrete peptides onto the skin.  X-
irradiated (9 Gy; n = 10) or not treated (n = 10) frogs were injected with 2 nmol/g of 
norepinephrine at 3 or 10 days after treatment (n = 5 in each treatment at both time 
points).  N.S., no significant different in the peptide concentrations recovered by two-
tailed Student‟s t test after log transformation (p = 0.0601 at day 3; p = 0.6178 at day 
10). 
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cause other effects besides the destruction of lymphoid cells, and it is possible that the X-
ray irradiation could have caused damage to the skin.  If this were true, then peptide 
defenses could have been impaired and could have caused the increased susceptibility 
observed in irradiated and exposed frogs.  We checked all frogs in the previous study 
over time for visual signs of skin damage after irradiation and exposure to B. 
dendrobatidis, and there was never any evidence of obvious skin damage.  Histological 
sections of irradiated skin also showed no signs of damage, as epithelial cells and 
granular glands were intact (Fig. 3-2B).  We also evaluated the concentrations of skin 
peptides that are secreted after irradiation and injection with 2 nmol/g of norepinephrine 
as compared to frogs that were not irradiated.  There was no significant difference 
between the induced peptide concentrations after norepinephrine stimulation between 
irradiated and nonirradiated controls (Fig. 3-2C), further suggesting that irradiation did 
not impair innate immunity in the skin.  Taken together, we interpreted the increased 
susceptibility to infection observed after B. dendrobatidis exposure and X-ray irradiation 
in X. laevis as evidence of impaired adaptive immune responses. 
 
Immunization of X. laevis against B. dendrobatidis induced a high-titer systemic 
antibody response 
 
 With the knowledge that adaptive immunity appeared to be involved in protection 
of X. laevis from B. dendrobatidis infections, we next determined whether a systemic 
response could be generated in X. laevis after immunization with B. dendrobatidis.  X. 
laevis individuals were immunized three times over a six week period with heat-killed B. 
dendrobatidis isolate JEL 197 cells, while control frogs were injected with vehicle alone 
(APBS).  Every week for four weeks after the last immunization, serum samples were 
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taken by heart puncture from a subset of frogs and evaluated for B. dendrobatidis-specific 
antibodies in an ELISA assay.  Preimmune serum samples were taken from a small group 
of frogs before the immunization protocol, and most frogs were bled only once 
throughout this experiment.  Immunization with B. dendrobatidis led to significantly 
elevated IgM and IgY responses that were specific to B. dendrobatidis, regardless of 
whether serum samples were tested against whole cultures (mature sporangia and 
zoospores together) or zoospores alone.  Significantly greater IgY binding to B. 
dendrobatidis was observed in immunized frogs compared to control individuals at all 
time points, except at day 28 in the assay against whole cultures.  There was a peak 
antibody response at 14 days after the final immunization, with the B. dendrobatidis-
specific IgY responses waning beginning at day 21 (Fig 3-3A).  Frogs injected with 
APBS alone showed low B. dendrobatidis-specific IgY titers across all time points 
(<1/800).  However, in B. dendrobatidis-immunized frogs, IgY titers ranged from 1/800 
to 1/6400 at day 14, and remained high (up to 1/3200) at days 21 and 28 (Fig. 3-3B).  
These data demonstrated that a robust systemic antibody response can be generated in X. 
laevis that are immunized with B. dendrobatidis, and that this response can persist for at 
least one month. 
 
Immunoglobulins in skin mucus 
 In response to B. dendrobatidis immunization, X. laevis was capable of 
developing a systemic antibody response, however B. dendrobatidis infects the skin of 
amphibians, and it is possible that a systemic response may not be productive in clearing 
the infection.  An adaptive response in the mucus would be more beneficial to control or  
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Figure 3-3.  Immunization of X. laevis against B. dendrobatidis (Bd) induced 
production of a high-titer antibody response.  Frogs were immunized three times 
over a six week period.  After the final immunization, blood was drawn each week for 
4 weeks by cardiac puncture.  Preimmune controls were drawn prior to immunization 
(n = 20).  B. dendrobatidis-specific IgY serum antibody binding activity (OD450) was 
measured by ELISA in frogs either immunized with heat-killed B. dendrobatidis or 
injected with vehicle alone (APBS).  (A) B. dendrobatidis-specific IgY in the serum 
(1/100 dilution) of APBS-injected or B. dendrobatidis-immunized frogs at day 7, 14, 
21, and 28 (n = 10 at all time points except day 28 where n = 7) after the last injection.  
The left panel shows binding activity against a mixture of mature sporangia and 
zoospores.  The right panel shows binding activity against zoospores alone.  Mean 
OD450 values were significantly different from preimmune serum values at all time 
points after log transformation by one-way ANOVA with Tukey post hoc test (p < 
0.01).  *, Significantly higher binding values compared to APBS controls after log 
transformation by two-tailed Student‟s t test (p ≤ 0.05).  (B) B. dendrobatidis-specific 
IgY titers for APBS-injected (left panel) or B. dendrobatidis-immunized (right panel) 
frogs in preimmune (n = 20) and day 7, 14, 21, and 28 (n = 10 at all time points except 
day 28 where n = 7) serum samples as determined by ELISA. 
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clear the pathogen.  To evaluate whether X. laevis skin mucus contained 
immunoglobulins, mucosal secretion was induced by injecting 80 nmol/g of 
norepinephrine into the skin of X. laevis individuals that had previously been exposed to 
B. dendrobatidis approximately 5 months earlier.  Mucosal secretions were collected in 
collection buffer, lyophilized, and resuspended in a buffer containing protease inhibitors 
before being tested for the presence of IgM, IgY, and IgX immunoglobulins by ELISA.  
All five individual X. laevis tested had significant levels of all three immunoglobulin 
classes in their mucosal secretions, with the exception of IgX in frog #5, when compared 
to an irrelevant serum control (1% normal rabbit serum) by one-way ANOVA with 
Tukey post hoc test (p < 0.01) and two-tailed Student‟s t test (p ≤ 0.025) (Fig. 3-4A).  To 
calculate the concentration of immunoglobulins being secreted onto the surface of the 
skin, we used purified IgM, IgY, and IgX at known concentrations to create a standard 
curve in an ELISA assay.  Using these purified standards, we determined that, on 
average, IgM is secreted at approximately 98 µg/ml in mucus, IgY at approximately 801 
µg/ml in mucus, and IgX at approximately 1671 µg/ml in mucus (Fig. 3-4B).  As IgX is 
considered the equivalent of mammalian IgA (149), it may not be surprising that it is the 
most concentrated immunoglobulin in the skin mucus. 
 X. laevis that were previously exposed to B. dendrobatidis had high 
concentrations of immunoglobulins present in the mucus, but the question remained as to 
whether any antibodies secreted were specific for B. dendrobatidis.  To test this, the 
reconstituted mucosal secretions were tested for binding activity against B. dendrobatidis 
in an ELISA assay.  All mucus samples were diluted to 1 mg/ml, and all showed 
significant binding to B. dendrobatidis as compared to an irrelevant serum control (1%  
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Figure 3-4.  Total and pathogen-specific antibodies in X. laevis mucosal 
secretions.  (A) Total binding activity of monoclonal antibodies specific for X. laevis 
immunoglobulins in mucosal secretions (5 mg/ml concentration of total proteins; n = 
5) compared to an irrelevant serum control (1% normal rabbit serum) as evaluated by 
ELISA.  (B) Using purified X. laevis IgM, IgY, and IgX as standards, total antibodies 
of each class in the mucus of the same frogs as in panel A were quantified by ELISA.  
(C) B. dendrobatidis-specific immunoglobulin binding activity in the mucus of the 
same frogs as in panels A and B compared to an irrelevant serum control (1% normal 
rabbit serum).  *, For panels A and C, significantly higher OD450 values for each frog 
and each immunoglobulin class after log transformation by one-way ANOVA with 
Tukey post hoc test (p < 0.01).  All values were also significantly higher from the 
irrelevant serum control after log transformation by two-tailed Student‟s t test (p ≤ 
0.025). 
58 
 
normal rabbit serum) by one-way ANOVA with Tukey post hoc test (p < 0.01) and two-
tailed Student‟s t test (p ≤ 0.025) (Fig. 3-4C).  These data suggested that X. laevis, and 
potentially other amphibian species, were capable of secreting immunoglobulins onto the 
surface of the skin via mucosal secretions.  After exposure to B. dendrobatidis, some of 
these immunoglobulins can bind to B. dendrobatidis and may play a role in resistance 
against this pathogen on the skin.  However, future studies need to be performed to 
determine whether immunoglobulins specific for B. dendrobatidis are increased after 
exposure, and whether these immunoglobulins are protective. 
 
Discussion 
 Along with the work described in the previous chapter, these studies were the first 
to systematically explore the immune defenses of X. laevis against the newly emerging 
fungal pathogen B. dendrobatidis.  These studies are necessary to understand resistance 
or susceptibility to B. dendrobatidis infection.  The data from this chapter strongly 
suggest that a component of adaptive immunity is playing a role in the protection of X. 
laevis, a resistant species, from lethal B. dendrobatidis infections. 
 Although X. laevis is resistant to B. dendrobatidis and does not die after exposure, 
the skin becomes infected.  After experimental exposure, zoospores can be observed in 
skin swabs from untreated frogs at 11 days postinfection, a time that corresponds to 
approximately three cycles of replication at optimal B. dendrobatidis temperatures.  By 
days 20 and 30, the intensity of infection significantly increases before waning to very 
low levels within 44 days (Fig. 3-1A).  The kinetics of infection and clearance in 
untreated but exposed X. laevis suggests that immune defenses are activated within 30 
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days.  The same kinetics are observed in individuals that have been irradiated with X-rays 
at a dose known to inhibit skin allograft rejection, tumor rejection, and ranavirus 
resistance (106, 180, 181, 201).  However, in irradiated frogs, the infection intensity is 
almost two-logs higher than the intensity seen in untreated frogs at day 20 and one-log 
higher at day 30 (Fig. 3-1A).  X-irradiation impacted the number of leukocytes present in 
the spleen (Fig. 3-2A), but did not damage the skin (Fig. 3-2B) nor impair the ability to 
secrete peptides onto the surface of the skin (Fig. 3-2C).  Thus, the most direct impact of 
X-irradiation was the reduction of the number of leukocytes available for an adaptive 
immune response, although it is possible that the irradiation induced a stress response that 
resulted in the release of corticosteroids that would also suppress the immune system.  
The individuals that were irradiated then exposed also lost significantly more weight 
compared to untreated and exposed controls.  This weight loss was not attributed to the 
irradiation protocol, as irradiated frogs that were left unexposed maintained their weights 
(Fig. 3-1B).  Although no frogs died due to exposure to B. dendrobatidis, the increased 
infection intensities and weight loss in irradiated and exposed frogs suggest that an 
irradiation-sensitive component of the adaptive immune system is involved in clearance 
of B. dendrobatidis infections in X. laevis. 
 Contrary to data previously discussed (Fig. 2-3 C, D, E, and F), peptide depletion 
by norepinephrine injection did not increase susceptibility to B. dendrobatidis after 
exposure in this experiment.  One injection with norepinephrine is enough to severely 
reduce peptide defenses in the skin of X. laevis, however they still retain a small amount 
of peptides in the skin.  Recent work in our lab by Scott Fites and Whitney Gammill has 
suggested that at least two injections with norepinephrine are necessary to fully deplete 
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the skin of its peptide stores.  The data that one injection of norepinephrine would not 
necessarily fully deplete the frog of its peptides may explain why we didn‟t see any 
increased susceptibility in these frogs.   
 When these studies were initiated little was known about the adaptive immune 
responses in amphibians against B. dendrobatidis.  Our studies have shown that an 
irradiation-sensitive component of adaptive immunity plays an important role in 
inhibiting B. dendrobatidis infection.  Experimental immunization of X. laevis to B. 
dendrobatidis led to the production of a high-titer class-switched IgY response that was 
specific to B. dendrobatidis (Figs. 3-3A and B).  This study did not determine the T cell 
contribution to this response, but it is known that the induction of high-titer antibody 
responses in X. laevis, as well as the switch from IgM to IgY, is T cell-dependent (23, 
222).  Thus, the generation of high-titer antibody responses after immunization suggests 
that T cells are being activated alongside B cells. 
 B. dendrobatidis is a skin pathogen, and it is unknown if a systemic adaptive 
immune response would be generated after infection.  In order to determine how adaptive 
immunity could be protecting the skin of amphibians, we decided to investigate whether 
immunoglobulins were present in the skin mucus.  Immunoglobulins are known to be a 
component of mucus in fish (134, 198) and mammals (43, 140).  In mammals, secretion 
of IgM and IgA is achieved when polymeric IgM and IgA bind to polymeric Ig receptors 
(pIgR) present on mucosal epithelial cells (33, 99).  After binding to pIgR on the 
basolateral side of the epithelial cells, the antibody/pIgR complexes are endocytosed and 
transported via endosomes to the apical plasma membrane.  At the apical plasma 
membrane, pIgR is cleaved into secretory component (SC) and the endosome fuses with 
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the membrane, releasing both SC and secretory IgM and IgA into the mucus (119, 120, 
147).  No reports have previously determined whether antibodies could be found in 
amphibian mucus.  However, pIgR from X. laevis has been isolated and characterized 
(31), suggesting that antibodies could be secreted into the mucus of amphibians. 
 This work found that antibodies of all three major classes (IgM, IgY, and IgX) 
were present in the skin mucus of X. laevis that had been previously exposed to B. 
dendrobatidis.  IgX is considered to be the amphibian equivalent of human IgA, since 
IgX-secreting B cells were determined to be found in high quantities in the gut epithelium 
of X. laevis but barely detectable in the liver and spleen (149).  The presence of all three 
classes in the mucosal secretions suggests that all three classes may play a role in 
protecting the skin (Fig. 3-4).  In an ELISA assay, mucosal antibodies from the 
previously exposed X. laevis individuals bound specifically to B. dendrobatidis (Fig. 3-
4C), although it is possible that these antibodies may bind nonspecifically to many 
pathogens.  Future experiments should be performed to determine whether experimental 
exposure to B. dendrobatidis induces an increase in pathogen-specific antibodies in the 
mucus.  Research also needs to be conducted into whether these mucosal 
immunoglobulins are protective.  One potential method of protection afforded by 
mucosal antibodies is the opsonization of pathogens for destruction by phagocytes or 
complement proteins.  If the immunoglobulins present in mucus are determined to be 
protective, it may be beneficial to develop a method of immunizing across the skin of 
amphibians to increase resistance against B. dendrobatidis in susceptible species. 
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CHAPTER IV 
 
 
INHIBITION OF AMPHIBIAN LYMPHOCYTE RESPONSES BY 
BATRACHOCHYTRIUM DENDROBATIDIS 
 
Abstract 
 Batrachochytrium dendrobatidis is a chytrid fungus that causes the lethal skin 
disease chytridiomycosis in amphibians.  Chytridiomycosis is an emerging infectious 
disease affecting amphibian populations around the world.  Our previous studies of the 
effects of X-irradiation in Xenopus laevis suggested that adaptive immunity is an 
important component of resistance to B. dendrobatidis infection in this species.  
However, lack of extensive lymphocyte infiltration in diseased skin suggests an impaired 
immune response.  A mechanism to explain impaired immunity has not been described.  
We show here that B. dendrobatidis mature sporangia, but not zoospores, have the 
capacity to inhibit the proliferation of mitogen-stimulated B and T lymphocytes from X. 
laevis.  This inhibition occurs even when the cells are separated from the lymphocytes by 
a cell-impermeable membrane in a transwell assay suggesting the release of a soluble 
inhibitory factor or factors.  Activated lymphocytes from Rana pipiens are also inhibited 
after co-culture with the pathogen suggesting that the inhibitory effect is not limited to 
one amphibian species.  The mechanism of inhibition appears to be induction of 
lymphocyte apoptosis.  Although both B and T cell responses are inhibited by B. 
dendrobatidis in vitro, T lymphocytes appear to be more sensitive to the induction of 
apoptosis.  Taken together, these data define a specific mechanism by which B. 
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dendrobatidis can impair development of a protective immune response.  They strongly 
suggest that B. dendrobatidis has evolved strategies to resist adaptive immune defenses in 
order to survive in the skin of amphibians. 
 
Introduction 
 Many species of fungi are capable of inducing a wide variety of diseases.  These 
infections have become more relevant to human health in the recent past due to an 
increase in the population of immunocompromised hosts (197).  Hosts with competent 
immunity are able to stave off fungal infections, utilizing both innate and adaptive 
immune responses.  Initial recognition of fungal pathogens is achieved by pattern 
recognition receptors, including toll-like receptors, on both phagocytes and dendritic 
cells.  Both cell types become activated, leading to the secretion of pro-inflammatory 
cytokines, release of antimicrobial peptides or reactive oxygen intermediates, and 
activation of cells involved in adaptive immunity.  T lymphocytes become primed, with 
Th1 cells stimulating phagocytosis or neutrophil degranulation, Th2 cells activating 
antibody responses in B lymphocytes, and cytotoxic T cells secreting antimicrobial 
factors.  The antibodies produced by B cells can opsonize fungal cells either for increased 
phagocytosis or for complement-mediated killing.  Both innate and adaptive responses 
are required for full protection from fungi in mammals, although the extent to which both 
systems are activated is dependent on the fungal species (rev. in 197).  Although hosts 
appear to have sufficient defenses against fungal pathogens to successfully eliminate 
infection, certain fungi have evolved methods to evade immunity by suppressing adaptive 
immune responses. 
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 Two metabolites produced by fungi that have the capability to modulate adaptive 
immunity are cyclosporine and gliotoxin.  Cyclosporine was initially identified as a 
metabolite of the fungus Tolypocladium inflatum Gams (27), although it was also found 
to be produced by Cylindrocarpon lucidum Booth (163).  Cyclosporine is an 11 amino 
acid cyclical peptide with a unique unsaturated C-9 amino acid (163).  It possesses not 
only mild antifungal activity, but also immunosuppressive properties without being toxic 
to lymphocytes (26-28).  Cyclosporine has the capacity to inhibit the production of 
antibodies against T-dependent antigens, to impede cell-mediated cytolysis, to prevent 
rejection of skin grafts, and to suppress delayed-type hypersensitivity responses (rev. in 
87).  All inhibitory properties were more marked in T cells than in B cells (87).  
Cyclosporine prevents the activation and proliferation of T cells by binding to cyclophilin 
and forming a heterodimeric complex.  This complex binds to calcineurin, which is only 
present in T cells, and inhibits the production of IL-2 which reduces T cell differentiation 
and activation (80).  However, lymphocytes already activated are not affected by 
cyclosporine, and cyclosporine effects are reversible (87). 
 Gliotoxin is a metabolite produced by multiple fungal species within the genera 
Aspergillus, Penicillium, and Trichoderma.  Gliotoxin is an epipolythiodioxopiperazine 
immunosuppressive mycotoxin that is regulated by LaeA, a transcription factor that 
regulates secondary metabolism in Aspergillus fumigatus (13).  Transcription of gliotoxin 
genes is upregulated after the onset of aspergillosis in A. fumigatus-infected hosts (138).  
The toxin has multiple effects on mammalian cells, including downregulating the 
oxidative burst pathway in polymorphonuclear leukocytes via disrupting the production 
of NADPH oxidase complexes (221), as well as inhibiting the activation of NF-κB in B 
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and T lymphocytes (159).  By preventing NF-κB activation, all the cytokines necessary 
for an effective adaptive immune response are inhibited, abrogating B and T cell 
stimulation (159).  Mice treated with gliotoxin in vivo show significant apoptosis of B 
cells (215), although gliotoxin may also activate apoptosis in polymorphonuclear 
leukocytes, peripheral blood mononuclear cells, and macrophages (13). 
 The work so far presented in this thesis gives evidence that the adaptive immune 
system of amphibians is necessary in order to fully protect species from lethal B. 
dendrobatidis infections.  Although this work was the first to fully explore adaptive 
immunity against this pathogen, other studies have been conducted to determine that 
adaptive immunity is required for protection.  In two New Zealand amphibian species, 
Litoria ewingii and Litoria raniformis, both of which are susceptible to B. dendrobatidis, 
frogs that were initially exposed to B. dendrobatidis and treated with chloramphenicol 
were able to clear the fungus within 35 days after re-exposure in the absence of the drug 
(176).  Boreal toads (Bufo boreas) that survived an initial exposure to B. dendrobatidis in 
situations in which they could choose a dry environment were able to survive longer after 
re-exposure in a constant wet environment, suggesting the involvement of acquired 
immunity in protection (C. Carey, personal communication).  However, the lack of 
extensive lymphocyte infiltration within the skin of infected frogs has been interpreted to 
suggest that adaptive immune responses against B. dendrobatidis are poor (15, 162).  In a 
recent microarray study, it was determined that several adaptive immune system genes 
were downregulated after B. dendrobatidis infection, including B-cell translocation gene, 
cutaneous T-cell lymphoma associated antigen, and complement factors.  This 
downregulation may suggest that B. dendrobatidis has the capacity to suppress activation 
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of adaptive immune responses after infection (175).  No studies have been published 
evaluating whether B. dendrobatidis can interfere with adaptive immunity, and my work 
focused on characterizing the effects of B. dendrobatidis on the activation of X. laevis 
lymphocytes in vitro. 
 Here we show that X. laevis lymphocytes activated by a mitogen or killed bacteria 
fail to proliferate when cultured with live or dead B. dendrobatidis cells (mixed 
zoospores and mature sporangia).  The inhibition of proliferation is maintained even 
when B. dendrobatidis cells are physically separated from the stimulated lymphocytes by 
a 0.4 µm pore-size membrane in a transwell assay.  Purified zoospores alone are also 
capable of inhibiting proliferation of activated lymphocytes over the three days of 
culture; however, the effect is lost if zoospores are heat-killed preventing further 
maturation, and it cannot be demonstrated when zoospores are separated from the 
lymphocytes by a cell-impermeable membrane.  The inhibitory activity of B. 
dendrobatidis is not specific to X. laevis as proliferation of stimulated lymphocytes from 
another amphibian species, Rana pipiens, is also inhibited in the presence of B. 
dendrobatidis.  The apparent mechanism of inhibition by the fungal factor is induction of 
lymphocyte apoptosis.  Characterization of the fungal factor or factors responsible for the 
inhibition and apoptosis is an active area of continuing research.  Collectively, these data 
strongly suggest that B. dendrobatidis has evolved mechanisms to evade adaptive 
immune responses giving it a survival advantage in amphibian skin once an infection is 
established. 
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Materials and Methods 
 
Frogs 
 Outbred Xenopus laevis frogs ranging in size from approximately 50 to 100 g 
were purchased from Xenopus I (Dexter, MI) and held in polystyrene containers at a 
density of about 10 frogs per 16 liters of dechlorinated tap water.  Three times each week, 
the frogs were fed ground beef heart and their water was changed.  Outbred Rana pipiens 
adults ranging in size from approximately 20 to 40 g were purchased from Connecticut 
Valley Biological (Southampton, MA) and held in polystyrene containers at a density of 
about 5 frogs per tank.  Containers were tilted slightly, and enough dechlorinated tap 
water was added to cover one end of the tank leaving the other end dry to allow the frogs 
access to dry space.  Three times each week, R. pipiens were fed live crickets and their 
water was changed.  All containers were kept between 20 - 24°C.  All animal procedures 
were approved by the Vanderbilt University Medical Center Institutional Animal Care 
and Use Committee. 
 
Lymphocyte culture 
 Lymphocytes were isolated from the spleen and cultured as previously described 
(185) in Leibovitz (L-15) culture medium (Sigma, St. Louis, MO) diluted to amphibian 
tonicity and supplemented with 100 U/ml penicillin, 100 g/ml streptomycin, 1.25 X 10-2 
M sodium bicarbonate, 5 X 10
-5
 M 2-mercaptoethanol, 2-mM L-glutamine, and 1% heat-
inactivated fetal calf serum (Atlanta Biologicals, Lawrenceville, GA).  After sacrifice of 
the frogs, spleens were removed using sterile technique and placed in a small volume of 
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L-15.  Each spleen was dissociated between two sterile frosted slides and washed, and 
lymphocytes were enriched by centrifugation over Ficoll-Hypaque cushion ( = 1.119; 
Sigma, St. Louis, MO), counted, and resuspended at a known concentration in L-15. 
 
Lymphocyte inhibition assays 
 Lymphocytes from X. laevis or R. pipiens were plated in a 96-well round-bottom 
plate at 1 X 10
5
 cells per well (5 X 10
5
/ml).  PHA (2 µg/ml) or heat-killed (100°C for 30 
minutes ) Aeromonas hydrophila cells originally isolated from a diseased Wyoming toad 
(216, 217) (2.5 X 10
6
 cells/ml) were added to stimulate T or B cell proliferation, 
respectively, as previously described (144, 185).  B. dendrobatidis whole cultures 
(mature sporangia and zoospores) or zoospores alone from either isolate JEL 197 (135) or 
JEL 275 (42) were added to the wells following re-suspension in L-15.  Zoospores were 
isolated as previously described (187).  Briefly, zoospores were harvested by flooding the 
agar surface of 7-day old cultures on 1% tryptone agar (1 g tryptone, 1 g agar, 100 ml 
water) using about 3.0 ml of sterile 1% tryptone broth (1 g tryptone, 100 ml water) twice.  
The broth containing zoospores was passed over sterile nylon spectra/mesh filters (20 µm 
mesh opening; Spectrum Laboratories, Rancho Dominguez, CA) to remove mature cells, 
and zoospores were re-suspended in L-15.  For experiments in which B. dendrobatidis 
was heat-killed, B. dendrobatidis was treated at 60°C for 10 minutes before addition to 
culture.  Plates containing lymphocytes were incubated at 26°C in an atmosphere of 5% 
CO2/95% air for 3 days before harvesting (185).  All wells were pulsed with 0.5 µCi 
3
H-
thymidine (5 µCi/ml, specific activity 2 Ci/mmole) (PerkinElmer, Waltham, MA) 24 
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hours prior to harvesting, and overall proliferation, measured as 
3
H-thymidine uptake, 
was quantified as counts per minute (CPM) using a scintillation counter. 
 
Transwell assays 
 Lymphocytes from X. laevis (5 X 10
5
 cells per well) were plated in a 24-well 
transwell plate with 0.4 µm pore-size transwell inserts (Corning, Corning, NY) at a final 
density of 8.3 X 10
5
 cells/ml.  PHA was added to achieve a final concentration of 2µg/ml.  
Mixed cultures of B. dendrobatidis sporangia and zoospores (8.3 X 10
5
 cells/ml) or 
zoospores alone (1.7 X 10
7
 cells/ml) of isolate JEL 197 were added above the transwell 
inserts (8.3 X10
5
 cells/ml).  In co-culture control wells, B. dendrobatidis cells were added 
directly to lymphocytes, and media was added above the insert.  In one experiment, 5 X 
10
5
 lymphocytes were plated along with zoospores above the insert to determine whether 
cell contact was necessary for zoospore production of an inhibitory factor.   Plates were 
incubated at 26°C for 3 days before harvesting.  Wells containing lymphocytes were 
pulsed with 
3
H-thymidine 24 hours prior to harvesting.  The lymphocytes were 
transferred to a 96-well round bottom plate for ease of harvesting, and overall 
proliferation was measured as CPM using a scintillation counter. 
  
Apoptosis assays 
 Lymphocytes from X. laevis were plated in a 24-well transwell plate with 0.4 µm 
pore-size transwell inserts at 1.7 X 10
6
 cells/ml.  Mixed sporangia and zoospores of B. 
dendrobatidis isolate JEL 197 were added above the transwell inserts at a density of 3.3 
X 10
7
 cells/ml.  Control inserts were filled with media alone.  Cultures were incubated for 
70 
 
24, 48, 72, or 96 hours at 26°C before use in flow cytometry.  To analyze the percent of 
apoptotic cells, cells were stained with a FITC-conjugated Annexin V Apoptosis 
Detection Kit according to manufacturer‟s instructions (BD Pharmingen, San Diego, 
CA).  Briefly, lymphocytes were washed with APBS and resuspended in 1X binding 
buffer at 1 X 10
6
 cells per ml.  Approximately 1 X10
5
 lymphocytes were stained with 5 
µl Annexin V-FITC and 1 µl propidium iodide (PI) (50 µg/ml).  Control preparations of 
cells were left unstained or stained with Annexin V only or PI only.  Cells were analyzed 
by flow cytometry with the assistance of the Vanderbilt Flow Cytometry core.  Cells 
were gated based on FITC and PI positivity, and those cells that were FITC
+
/PI
-
 were 
considered to be undergoing apoptosis (223). 
 For analysis of apoptosis in B or T cell populations, lymphocytes were plated in 
24-well plates (no transwell inserts) at 1.7 X 10
6
 cells/ml.  Mixed sporangia and 
zoospores of B. dendrobatidis isolate JEL 197 were heat-killed at 60°C for 10 minutes 
and plated with lymphocytes at 1.7 X 10
7
 cells/ml.  Plates were incubated for 48 hours at 
26°C before use in flow cytometry.  All lymphocytes were stained with anti-Xenopus 
monoclonal antibodies specific for MHC class II (14A2) (186), followed by polyvalent 
allophycocyanin (APC)-conjugated goat anti-mouse antibodies (0.5 mg/ml).  [All 
lymphocytes are MHC class II positive in adults of this species (73, 79, 186).] This 
allowed us to select for lymphocytes while gating out B. dendrobatidis cells.  After 
washing, the MHC II
+
 cell population was divided and stained either with monoclonal 
antibodies specific for IgM (6.16) (22) to identify B cells or with monoclonal antibodies 
specific for CD5, a pan T-cell marker in Xenopus  (2B1) (118), to identify T cells.  Both 
populations were further stained with polyvalent phycoerythrin (PE)-conjugated goat 
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anti-mouse antibodies (0.5 mg/ml).  All antibody stocks contained 24 µg/ml of 7-
aminoactinomycin D (7-AAD) to gate out dead cells.  The IgM
+
 fraction and the CD5
+
 
fraction were washed and resuspended in 1X binding buffer before staining with 5 µl 
FITC-conjugated Annexin V according to manufacturer‟s instructions.  Control 
populations of lymphocytes were unstained, stained with 7-AAD only (24 µg/ml), with 
APC only (0.5 mg/ml), with PE only (0.5 mg/ml), or with FITC only.  Cells were 
analyzed by flow cytometry with the assistance of the Vanderbilt Flow Cytometry core.  
B cells were gated on the IgM-PE positive population while T cells were gated on the 
CD5-PE positive population.  Both B and T cells were then analyzed for dual staining for 
Annexin V (FITC) and 7-AAD, and those cells that were FITC
 
positive and 7-AAD
 
negative were considered to be apoptotic.  To determine the extent of apoptosis 
regardless of cell type, lymphocytes were also gated on MHC II-APC positive population 
before being analyzed for Annexin V (FITC) and 7-AAD fluorescence. 
 
Statistical comparisons 
 All parameters compared were averaged, and the mean values ± standard error of 
the mean were compared by one-tailed or two-tailed Student‟s t test or one-way analysis 
of variance (ANOVA) with planned comparisons (Tukey post hoc tests) as detailed in the 
figure legends.  A p value ≤ 0.05 was considered to be statistically significant.  Error bars 
shown in all figures represent the standard error of the mean.  If no error bar is shown, the 
standard error of the mean was less than the diameter of the symbol. 
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Results 
 
Lymphocytes from X. laevis immunized against B. dendrobatidis failed to proliferate 
in response to culture with the fungus 
 
 As previously shown, X. laevis immunized against B. dendrobatidis had high-titer 
IgY antibodies in the serum that were specific for the pathogen, suggesting that a robust 
adaptive immune response had been generated (Fig. 3-3).  To further show that adaptive 
responses had been activated, we isolated lymphocytes from immunized frog spleens and 
cultured them with B. dendrobatidis cells.  The lymphocytes should recognize their 
respective antigens on B. dendrobatidis and proliferate in response to culture with the 
pathogen.  The lymphocytes from the immunized frogs failed to proliferate in response to 
culture with B. dendrobatidis, as determined by significantly higher 
3
H-thymidine uptake 
compared to lymphocytes alone.  This increase in 
3
H-thymidine counts per minute was 
not due to B. dendrobatidis taking up the isotope, as B. dendrobatidis cells alone showed 
very low counts per minute (Table 4-1).  There was no inherent defect in proliferation of 
these lymphocytes, as they all responded and proliferated significantly when stimulated 
with the T cell mitogen phytohemagglutinin (PHA) (Table 4-1).  These data led to our 
hypothesis that B. dendrobatidis is capable of inhibiting activation and proliferation of X. 
laevis lymphocytes, which would give the fungus a survival advantage in the skin after 
infection. 
 
B. dendrobatidis inhibited proliferation of activated T and B cells 
 To determine whether B. dendrobatidis can inhibit the proliferation of 
lymphocytes that had been activated, live or heat-killed B. dendrobatidis cells (mature  
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Table 4-1.  Spleen cell proliferation following immunization with B. dendrobatidis. 
1
Cells harvested at day 3 after in vitro culture.  
2
S. I.: Stimulation index = stimulated 
counts divided by background counts.  
3
Cells harvested at day 5 after in vitro culture.  
4
APBS control frogs were injected with amphibian phosphate buffered saline at days 
0, 14, and 28.  Cells were harvested at day 33.  
5
Bd frogs immunized with heat-killed 
B. dendrobatidis at days 0, 14, and 28.  Cells were harvested at day 33. 
*, Significantly greater than CPM of cells only, p ≤ 0.0005.  **, Significantly greater 
than CPM of cells only, p ≤ 0.005.  ***, Significantly greater than CPM of cells only, 
p ≤ 0.025. 
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sporangia and zoospores) were co-cultured with lymphocytes stimulated with either PHA 
(T cell stimulation) or heat-killed Aeromonas hydrophila bacteria (B cell stimulation) as 
described in materials and methods with the assistance of Scott Fites and Whitney 
Gammill.  As expected, lymphocytes stimulated with either PHA or A. hydrophila in the 
absence of B. dendrobatidis proliferated well.  When B. dendrobatidis was added to the 
stimulated lymphocytes, there was a significant dose-dependent reduction in proliferation 
as the numbers of fungal cells increased (Figs. 4-1A and B).  Live B. dendrobatidis 
inhibited PHA-stimulated proliferation significantly at all pathogen-to-lymphocyte ratios, 
whereas heat-killed B. dendrobatidis was less inhibitory showing consistent inhibition 
only at the two highest concentrations of added cells (Fig. 4-1A).  Heat-killed B. 
dendrobatidis also inhibited proliferation of lymphocytes stimulated with A. hydrophila 
(data not shown).  These data suggested that B. dendrobatidis was able to inhibit 
proliferation of B and T cells, and the inhibitory factor can be released by either live or 
dead cells. 
 
B. dendrobatidis secreted a soluble inhibitory factor 
 To better understand the nature of the lymphocyte inhibitory factor, we tested 
whether inhibition required cell-to-cell contact.  B. dendrobatidis sporangia and 
zoospores were separated from PHA-stimulated lymphocytes by a transwell filter.  B. 
dendrobatidis cells were prevented from coming into contact with lymphocytes; 
however, any molecules secreted by B. dendrobatidis could pass through the filter and 
interact with lymphocytes.  Lymphocytes stimulated with PHA in the absence of B. 
dendrobatidis showed a high level of proliferation.  When PHA-activated lymphocytes  
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Figure 4-1.  B. dendrobatidis (Bd) cells inhibited proliferation of X. laevis 
lymphocytes.  (A) Lymphocytes from frogs were isolated, stimulated with PHA (2 
µg/ml), and cultured with increasing numbers of either live or heat-killed B. 
dendrobatidis cells (isolate JEL 197).  Cell proliferation was measured as 
3
H-
thymidine uptake determined as CPM in a scintillation counter.  *, Significantly 
reduced 
3
H-thymidine uptake compared to PHA-stimulated lymphocytes in the 
absence of B. dendrobatidis by two-tailed Student‟s t test (p ≤ 0.05).  Data are 
representative of three similar experiments.  (B) Lymphocytes from frogs were 
isolated, stimulated with heat-killed A. hydrophila, and cultured with increasing 
numbers of live B. dendrobatidis cells.  Cell proliferation was measured by 
3
H-
thymidine uptake.  *, Significantly reduced 
3
H-thymidine uptake compared to A. 
hydrophila-stimulated lymphocytes in the absence of B. dendrobatidis by two-tailed 
Student‟s t test (p ≤ 0.0001).  Data are representative of three similar experiments. 
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were cultured in the presence of live B. dendrobatidis (equal numbers of B. dendrobatidis 
sporangia and lymphocytes) without being separated by a transwell filter, there was a 
severe reduction in proliferation.  When separated by a transwell filter, B. dendrobatidis 
retained the ability to inhibit lymphocyte proliferation at the same equal B. 
dendrobatidis-to-lymphocyte ratio, although the magnitude of inhibition was diminished 
in comparison to that observed when both cell types were cultured together (Fig. 4-2).  
These data suggested that the inhibition induced by B. dendrobatidis was likely due to a 
soluble factor, as the fungus was able to inhibit proliferation in activated lymphocytes 
even when separated from them by a transwell filter.  However, close proximity to the 
lymphocytes was necessary for maximal inhibition of proliferation. 
 
B. dendrobatidis zoospores did not inhibit lymphocyte proliferation 
 There are two discernible life stages of B. dendrobatidis.  The zoospore is the 
infectious life stage, and following infection, they mature into sporangia.  The 
experiments presented in Figs. 4-1 and 4-2 showing that B. dendrobatidis causes 
lymphocyte inhibition used cells from broth cultures containing both zoospores and 
maturing sporangia.  To determine if the ability to inhibit lymphocytes was specific to a 
particular life stage, we evaluated the ability of zoospores alone to inhibit proliferation.  
B. dendrobatidis zoospores of isolates JEL 197 and JEL 275 were purified as described in 
materials and methods and cultured directly with lymphocytes stimulated to proliferate 
with PHA.  During the three-day cultures, zoospores appeared to significantly inhibit the 
PHA-stimulated lymphocyte proliferation in a dose-dependent manner, regardless of the  
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  Figure 4-2.  B. dendrobatidis inhibited X. laevis lymphocyte proliferation even 
when physically separated by a transwell filter.  Lymphocytes were isolated, 
stimulated with PHA (2 µg/ml), and cultured with B. dendrobatidis either together 
(co-culture) or separated by a 0.4 µm pore-size filter (transwell) for three days.  Cell 
proliferation was measured as 
3
H-thymidine uptake using a scintillation counter.  *, 
Significantly reduced 
3
H-thymidine uptake in comparison with stimulated 
lymphocytes in the absence of B. dendrobatidis by one-way ANOVA with Tukey post 
hoc test (p < 0.01).  The data are representative of three similar experiments. 
78 
 
isolate tested (Fig. 4-3A).  It should be noted that greater numbers of zoospores were 
necessary to achieve the same inhibitory effect as that seen with B. dendrobatidis mixed 
cultures (Fig. 4-1A).  Because zoospores can mature rapidly at 26C, we tested whether 
heat-killed zoospores that were unable to develop to mature sporangia would inhibit.  In 
contrast to the live zoospores, heat-killed zoospores were incapable of inhibiting 
lymphocyte proliferation (Fig. 4-3B).  We next tested whether live zoospores could 
inhibit lymphocytes when separated from them by a transwell filter with the assistance of 
Sophia Gayek.  Even when zoospores vastly outnumbered the lymphocytes (a ratio of 
twenty zoospores to one lymphocyte), zoospores were unable to inhibit proliferation of 
PHA-stimulated lymphocytes.  The same numbers of zoospores, however, completely 
reduced proliferation when cultured directly with lymphocytes (Fig. 4-3C).  To determine 
whether zoospores needed to directly contact lymphocytes to release an inhibitory factor, 
an experiment was designed to place lymphocytes along with zoospores in the top 
chamber of the transwell and follow the effects on lymphocytes stimulated with PHA in 
the bottom chamber.  Although the developing zoospores were strongly inhibitory when 
cultured with lymphocytes in the lower chamber, they failed to release a factor that could 
diffuse into the lower chamber even when in direct contact with lymphocytes in the upper 
chamber (Fig. 4-3D).   These data suggested that zoospores alone were unable to inhibit 
activated lymphocytes unless they mature to sporangia.  Zoospores cultured alone in L-15 
for three days matured to a rounded-looking thallus with rhizoids.  Because zoospores 
were unable to inhibit lymphocyte proliferation when separated from lymphocytes by a 
cell-impermeable filter, they appeared to require additional time to develop to a stage that  
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Figure 4-3.  Live, but not dead, B. dendrobatidis zoospores inhibited proliferation of 
stimulated X. laevis lymphocytes in culture.  (A) Lymphocytes were isolated, stimulated 
with PHA (2 µg/ml), and cultured with increasing numbers of zoospores of isolate JEL 197 or 
JEL 275 for three days.  Proliferation was measured by 
3
H-thymidine uptake.  Zoospore 
inhibition of proliferation was observed in three additional co-culture experiments.  (B) 
Isolated lymphocytes were stimulated with PHA and increasing numbers of live or heat-killed 
(60°C, 10 min) zoospores were added.  Proliferation was measured by 
3
H-thymidine uptake.  
(C) Isolated lymphocytes were stimulated with PHA and cultured with zoospores either 
together (co-culture) or separated by a transwell filter for 3 days.  Cell proliferation was 
measured by 
3
H-thymidine uptake.  The data are representative of three similar experiments.  
(D) Lymphocytes (5 x 10
5
) were stimulated in the top chamber of a transwell culture plate and 
lymphocytes alone with PHA in the bottom chamber as shown.  In some wells, zoospores 
were cultured along with lymphocytes in the upper chamber to determine whether the 
interaction would result in inhibition of PHA-stimulated lymphocyte proliferation in the 
bottom chamber.  A-C, The symbols indicate significantly reduced CPM as compared to 
stimulated lymphocytes in the absence of zoospores by one-way ANOVA with Tukey post 
hoc test (**, p < 0.05; *, p < 0.01). 
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was actively releasing sufficient inhibitory factors to affect lymphocyte proliferation at a 
greater distance.   
 
Inhibition of proliferation by B. dendrobatidis was not specific to X. laevis 
 In order to demonstrate that the ability of B. dendrobatidis to inhibit lymphocytes 
was not limited to one amphibian species (X. laevis), we tested whether B. dendrobatidis 
could inhibit proliferation of lymphocytes from another amphibian species, Rana pipiens, 
a species that is susceptible to B. dendrobatidis infections and develops chytridiomycosis 
(158, 224, 237).  This work was completed with the assistance of Scott Fites and Whitney 
Gammill.  Live B. dendrobatidis (maturing sporangia and zoospores) were added directly 
to lymphocytes from R. pipiens that had been stimulated with either PHA or A. 
hydrophila, and lymphocyte proliferation was quantified.  Both B and T cells from R. 
pipiens proliferated well when stimulated with their respective mitogens and showed 
significantly decreased proliferation when B. dendrobatidis was added at a ratio of ten B. 
dendrobatidis cells to one lymphocyte (Figs. 4-4A and B).  These data suggested that B. 
dendrobatidis had the capacity to inhibit lymphocyte proliferation in more than one 
amphibian species. 
 
B. dendrobatidis induced apoptosis in resting lymphocytes 
 We next investigated the mechanism by which B. dendrobatidis inhibited 
lymphocyte proliferation.  Other pathogenic fungi, including Cryptococcus neoformans 
(45, 46, 143), Histoplasma capsulatum (6), and Aspergillus fumigatus (13, 215) induce 
hyporesponsiveness by activating apoptosis signaling pathways.  To determine if B. 
dendrobatidis induced apoptosis in lymphocytes, X. laevis lymphocytes were cultured  
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Figure 4-4.  B. dendrobatidis cells inhibited proliferation of mitogen-stimulated R. 
pipiens lymphocytes.  (A) Lymphocytes were isolated, stimulated with PHA (2 
µg/ml), and cultured with B. dendrobatidis (mixed sporangia and zoospores) for three 
days.  Proliferation was measured by 
3
H-thymidine uptake.  *, Significantly reduced 
3
H-thymidine uptake as compared to stimulated lymphocytes in the absence of B. 
dendrobatidis by one-way ANOVA with Tukey post hoc test (p < 0.01).  The data are 
representative of two replicate experiments.  (B) Lymphocytes were isolated, 
stimulated with heat-killed A. hydrophila (5 x 10
5
 cells/well; 2.5 x 10
6
 cells/ml), and 
cultured with B. dendrobatidis for three days.  Proliferation was measured by 
3
H-
thymidine uptake.  *, Significantly reduced 
3
H-thymidine uptake by one-way ANOVA 
with Tukey post hoc test (p < 0.05).  The data are representative of two similar 
experiments. 
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with live B. dendrobatidis in a transwell system, then analyzed for propidium iodide (PI) 
and Annexin V staining by flow cytometry every 24 hours for 96 hours after culture. 
Lymphocytes cultured in the absence of B. dendrobatidis showed low percentages of 
apoptotic cells (PI
-
 , Annexin V
+
) at all time points tested, although by 96 hours the 
percentage of apoptotic cells was beginning to increase due to cellular fatigue (Fig. 4-5).  
When cultured with B. dendrobatidis, the percentage of apoptotic lymphocytes was not 
different from control cells at 24 hours (Figs. 4-5A and 4-5E).  However, the percentage 
of apoptotic lymphocytes was significantly greater at both 48 and 72 hours of culture in 
comparison with control populations (Figs. 4-5B-C and 4-5E).  By 96 hours, the 
percentage of apoptotic lymphocytes was no longer significantly greater than controls 
(Figs. 4-5D and 4-5E).  Taken together, these data suggested that B. dendrobatidis 
induced hyporesponsiveness in lymphocytes by activating apoptosis signaling pathways 
rather than by disturbance of the membrane and direct induction of necrosis. 
 
B. dendrobatidis induced apoptosis largely in T cells 
 Many pathogenic fungi that induce apoptosis in lymphocytes largely affect T 
cells, including Cryptococcus neoformans (45, 46) and Histoplasma capsulatum (6).  
However, certain fungal pathogens, such as Aspergillus fumigatus, induce apoptosis in B 
cells or other antigen presenting cells (13, 215).  To determine if either B cells or T cells, 
or both, are affected by apoptosis after incubation with B. dendrobatidis, lymphocytes 
from X. laevis were cultured directly with heat-killed B. dendrobatidis cells at a ratio of 
ten B. dendrobatidis cells to one lymphocyte.  After 48 hours of culture, the lymphocytes 
were analyzed for apoptosis by flow cytometry.  Cells were gated based on either IgM- 
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Figure 4-5.  B. dendrobatidis induced apoptosis in X. laevis lymphocytes.  
Lymphocytes were isolated and cultured with B. dendrobatidis separated by a 
transwell filter (twenty B. dendrobatidis cells to one lymphocyte) and analyzed for 
percent apoptotic cells by flow cytometry.  Lymphocytes that were Annexin V
+
 and 
PI
-
 were considered to be apoptotic, whereas cells that were Annexin V
+
 and PI
+
 were 
considered to be dead (43).  (A-D) Flow cytometry plots when lymphocytes were 
stained with Annexin V and PI at (A) 24 hours, (B) 48 hours, (C) 72 hours, or (D) 96 
hours of incubation in the absence or presence of B. dendrobatidis.  The plots shown 
are representative of three independent experiments.  (E) Overall apoptosis in 
lymphocytes cultured in the absence or presence of B. dendrobatidis for 96 hours (n = 
3 frogs per time point).  The asterisks indicate significantly increased percentages of 
apoptotic cells as compared to lymphocytes cultured in the absence of B. 
dendrobatidis by two-tailed Student‟s t test (*, p < 0.025; **, p < 0.01). 
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positivity (B cells) or CD5-positivity (T cells) before determining 7-AAD and Annexin V 
staining.  In the absence of B. dendrobatidis, both IgM
+
 and CD5
+
 cells showed low 
percentages of apoptotic (7-AAD
-
, Annexin V
+
) cells (Figs. 4-6A and B).  When cultured 
with B. dendrobatidis, the percentage of apoptotic IgM
+
 B cells only increased modestly 
compared to control cells (Fig. 4-6A).  In contrast, the percentage of apoptotic CD5
+
 T 
cells increased significantly after culture with B. dendrobatidis (Fig. 4-6B).  The 
percentage of CD5
+
 T cells that were 7-AAD
+
, Annexin V
+
 after incubation with B. 
dendrobatidis also increased without an increase of necrotic (7-AAD
+
, Annexin V
-
) cells 
(Fig. 4-6B), suggesting that these cells underwent apoptosis.  These data indicated that 
the apoptosis induced by B. dendrobatidis upon culture with lymphocytes largely affected 
T cells, although some B cells may also be affected. 
 
Discussion 
 Understanding the pathogenesis of chytridiomycosis and immune defenses in the 
skin of amphibians against B. dendrobatidis infection is critical for developing a 
mitigation strategy to manage amphibian populations or protect amphibians in captivity.  
The skin is protected by both innate and adaptive immunity.  Antigens from skin 
pathogens are transported to the spleen where an immune response involving both B and 
T cells can develop (40, 72, 182).  It is likely that antigen presenting cells that reside in 
the skin would encounter an invasive pathogen, transport antigens to the spleen, and 
splenic lymphocytes would migrate back to the skin to respond locally in an effort to 
clear the pathogen.  Although an inflammatory response in skin consisting of infiltration 
of neutrophils, lymphocytes, and macrophages (162) can sometimes be detected, it is  
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Figure 4-6.  B. dendrobatidis induced apoptosis largely in X. laevis T cells, but 
modestly in B cells.  Lymphocytes were isolated and cultured with heat-killed B. 
dendrobatidis at a ratio of ten B. dendrobatidis cells to one lymphocyte for 48 hours.  
Lymphocytes were analyzed for percent apoptotic cells by flow cytometry as 
described in materials and methods.  Lymphocytes that were Annexin V
+
 and 7-AAD
-
 
were considered to be apoptotic, whereas lymphocytes that were Annexin V
+
 and 7-
AAD
+
 were considered to be dead.  (A) B cells were gated out as IgM
+
 cells.  (B) T 
cells were gated out as CD5
+
 cells.  Lymphocytes were cultured either in the absence 
(left plots) or presence (right plots) of B. dendrobatidis.  This figure is representative 
of two independent experiments. 
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inconsistent (15, 162).  This suggests the absence of an effective immune response to B. 
dendrobatidis (15, 162).  In addition, two global microarray studies in a closely related 
species, Silurana (Xenopus) tropicalis, showed little evidence for upregulation of 
immune-related genes in the tissues examined following exposure to B. dendrobatidis 
(175, 200).  In contrast to these observations, sublethal X-irradiation of X. laevis prior to 
exposure to B. dendrobatidis resulted in greater susceptibility to infection.  Irradiated 
frogs had significantly higher infection intensities on their skin and lost more weight 
compared to untreated and exposed controls (169).  This was correlated with reduced 
lymphocyte numbers and no apparent alteration of mucosal antimicrobial peptide 
defenses (169).  Thus, it appears that an irradiation-sensitive compartment of the adaptive 
immune system contributes to protection of X. laevis from B. dendrobatidis infection.  
 Our previous studies showed that X. laevis immunized with heat-killed B. 
dendrobatidis cells can develop a robust pathogen-specific IgM and IgY response (169).  
However, splenic lymphocytes from immunized frogs failed to proliferate after 
stimulation when co-cultured with killed B. dendrobatidis (Table 4-1).  We hypothesized 
that B. dendrobatidis is able to inhibit the proliferation of stimulated lymphocytes.  
Proliferation of lymphocytes activated with PHA and co-cultured with either live or heat-
killed B. dendrobatidis sporangia was significantly impaired in comparison with control 
PHA-stimulated cultures (Fig. 4-1A).  Similarly, lymphocytes stimulated by heat-killed 
A. hydrophila, an agent that induces vigorous B cell proliferation (144), became 
hyporesponsive when cultured in the presence of live B. dendrobatidis cells (Fig. 4-1B).  
These data suggest that B. dendrobatidis directly inhibits lymphocytes by a previously 
unknown mechanism in vitro.  We suggest that this capacity to inhibit lymphocytes may 
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help to explain the lack of evident lymphocyte infiltration in heavily infected skin (15, 
162). 
 Whole cultures of B. dendrobatidis with a mixture of zoospores and maturing 
sporangia retain the capacity to inhibit the proliferation of activated lymphocytes when 
physically separated from the lymphocytes by a 0.4 µm pore-size transwell filter.  This 
inhibition, however, is diminished in magnitude in comparison with that observed when 
lymphocytes are cultured in the same well with B. dendrobatidis (Fig. 4-2).  This 
suggests that factors produced by the fungus (small molecules or proteins) diffuse freely 
into the lymphocyte culture through the transwell filter when B. dendrobatidis is 
prevented from coming into contact with the lymphocytes.  Ongoing studies in our 
laboratory have demonstrated that supernatants of B. dendrobatidis cultured in sterile 
water overnight also inhibit stimulated B and T lymphocytes (S. Fites, unpublished 
observation).  These data suggest that B. dendrobatidis secretes a water-soluble molecule 
that interacts with lymphocytes and induces a signaling cascade that leads to 
hyporesponsiveness.  Studies to characterize the molecule responsible for this 
phenomenon are currently underway. 
 The zoospore life stage is the infectious stage of the B. dendrobatidis life cycle, 
and it is responsible for initiating the infection on the surface of frog skin.  To what 
extent zoospores come into direct contact with cells of the immune system is not clear.  
The process by which a zoospore moves from the surface of the skin to enter the cells of 
the stratum granulosum and stratum corneum are not yet well understood (228).  If they 
encounter lymphocytes, it is possible that the zoospores would be able to inhibit the 
proliferation of activated lymphocytes in order to increase their chances of entering the 
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more protected environment of epidermal cells.  Our work shows that purified live B. 
dendrobatidis zoospores can inhibit lymphocytes but only when they are cultured for 
three days in the presence of the lymphocytes (Figs. 4-3A).  Because heat-killed 
zoospores are unable to inhibit stimulated lymphocytes (Fig. 4-3B), we suggest that the 
cultured zoospores are developing to a more mature stage during the three days of 
culture, and the more mature cells are synthesizing and secreting the inhibitory factor.  
This interpretation is supported by the failure of purified zoospores to inhibit across a 0.4 
µm filter in a transwell assay even when they are co-cultured with lymphocytes in the 
upper chamber (Figs. 4-3C and D).  These data suggest that the maturing zoospores are 
able to directly inhibit lymphocytes in co-culture, but they are not producing the 
inhibitory molecule at concentrations sufficient for inhibition at a distance.  Because 
zoospores lack a cell wall (135, 162), we speculate that the inhibitory factor produced by 
sporangia may be part of the cell wall structure.   
 X. laevis is regarded as resistant to the lethal effects of B. dendrobatidis infection.  
B. dendrobatidis has been detected in archived specimens of X. laevis since 
approximately 1938 and appears to be endemic in wild populations (232).  It is possible 
that B. dendrobatidis has co-evolved with X. laevis for a long period of time.  To test 
whether the ability of B. dendrobatidis to impair lymphocyte function is specific only to 
X. laevis, we determined if stimulated lymphocytes from another species, R. pipiens, 
would be unable to proliferate when co-cultured with B. dendrobatidis.  Both stimulated 
B and T cells from R. pipiens showed significantly reduced proliferation when co-
cultured with B. dendrobatidis (Fig. 4-4).  These data suggest that the 
hyporesponsiveness induced by B. dendrobatidis is not specific to one species of 
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amphibians, and that it may utilize this mechanism to more effectively colonize the skin 
of all amphibians. 
 Pathogenic fungi, including Cryptococcus neoformans (45, 46, 143), Histoplasma 
capsulatum (6), and toxigenic species of Aspergillus (3, 13, 215) modulate adaptive 
immune responses and render lymphocytes, especially T cells, hyporesponsive by 
inducing apoptosis.  We evaluated whether B. dendrobatidis similarly induces apoptosis 
in amphibian lymphocytes.  Unstimulated lymphocytes cultured in the presence of B. 
dendrobatidis cells separated by a transwell filter showed significantly increased numbers 
of apoptotic cells (Annexin V
+
, PI
-
) over time in comparison with lymphocytes cultured 
in the absence of the pathogen (Fig. 4-5).  An evaluation of apoptosis in B and T cell 
populations after lymphocytes were co-cultured with heat-killed B. dendrobatidis cells 
indicated that both cell populations had increased percentages of apoptotic cells as 
compared to lymphocytes cultured in the absence of the pathogen, although the effect on 
B cells was modest compared to that seen in T cells (Fig. 4-6).  These data suggest that B. 
dendrobatidis induces apoptosis in lymphocytes, greatly reducing the number of 
lymphocytes that are available to proliferate after stimulation, and that apoptosis largely 
affects T cells.    
The hyporesponsiveness induced by B. dendrobatidis in lymphocytes from 
multiple species may help to explain why some species are very susceptible to fatal 
infections by this pathogen.  Innate and adaptive defenses within the skin may both be 
required for full resistance to B. dendrobatidis.  Both adaptive immune responses against 
B. dendrobatidis and antimicrobial peptides in the skin play a role in protecting X. laevis 
from infection (169, 191, and this thesis).  X. laevis has very effective antimicrobial 
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peptide defenses in the skin (169), which may help to limit the initial colonization by B. 
dendrobatidis zoospores.  The antimicrobial peptides present in the mucus may limit B. 
dendrobatidis to a degree that prevents the inhibitory molecule from reaching critical 
concentrations that would inhibit local lymphocyte proliferation.  However, in more 
susceptible amphibian species, many of which have very poor skin peptide defenses 
(234-236), B. dendrobatidis may continue to grow unchecked in the skin.  If the infection 
progresses quickly, the pathogen may produce and release sufficient inhibitory factors to 
diminish the capacity of lymphocytes to respond and control the infection.  The 
uncontrolled infection may then lead to the disruption of skin functions and death (226-
228). 
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CHAPTER V 
 
 
DISCUSSION AND FUTURE DIRECTIONS 
 
 My dissertation work is the first to systematically explore the immune responses 
of amphibians responding to infection with B. dendrobatidis.  It also provides the first 
experimental evidence that B. dendrobatidis has evolved a mechanism to evade adaptive 
immunity to give itself a survival advantage in the skin.  This interplay between the 
host‟s immune responses against the pathogen, and the pathogen‟s ability to evade these 
defenses, may explain a species‟ overall resistance to B. dendrobatidis.  Understanding 
what defenses are being mobilized, or whether B. dendrobatidis inhibits them, may allow 
scientists to create protocols that will increase resistance to B. dendrobatidis in the 
laboratory and eventually aid conservation efforts. 
 
Antimicrobial peptide defenses are critical for protection against B. dendrobatidis 
 X. laevis is considered resistant to B. dendrobatidis infections because infected 
individuals show no signs of chytridiomycosis (161) and the disease cannot be induced in 
frogs after experimental infection with a high dose of B. dendrobatidis zoospores (191).  
Previous work by the Rollins-Smith lab and others has shown that the effectiveness of an 
amphibian species‟ antimicrobial peptide defenses in inhibiting B. dendrobatidis growth 
in vitro is correlated with survival of that species in the wild or its resistance in laboratory 
exposure (235, 236).  My work shows that X. laevis skin secretions contain previously 
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identified X. laevis antimicrobial peptides, and that these natural mixtures of peptides are 
very effective at inhibiting B. dendrobatidis growth in vitro.  Purified antimicrobial 
peptides from X. laevis skin are also inhibitory alone with varying degrees of 
effectiveness.  These data show that X. laevis has very strong antimicrobial peptide 
defenses in the mucus that would protect it from initial infections or re-infections of B. 
dendrobatidis after exposure. 
 Although we demonstrate that the antimicrobial peptide defenses in X. laevis are 
robust, it is not known if individuals can secrete concentrations of peptides onto the 
surface of their skin at concentrations sufficient to inhibit B. dendrobatidis.  Natural 
mixtures of peptides are inhibitory at concentrations above 30 - 60 µg/ml.  My work 
concludes that X. laevis is capable of secreting mixtures of antimicrobial peptides well 
above these concentrations, both when chased in a simulated predator attack and when 
resting.  The resting frogs are only minimally handled, and thus the concentrations may 
be slightly higher than true resting frogs.  Nevertheless, X. laevis has the capability to 
secrete antimicrobial peptides at levels that are inhibitory to B. dendrobatidis and appears 
to secrete smaller, though still inhibitory, concentrations of peptides continually to 
protect the skin from infection. 
 In order to assess whether antimicrobial peptide defenses are necessary for the 
protection of frog skin from chytridiomycosis, we developed a protocol for depleting the 
skin of its peptides during the course of my work.  Frogs secrete their antimicrobial 
peptide stores when injected with norepinephrine.  There is a dose-dependent response of 
peptides secreted onto the surface of the skin after norepinephrine injection, with 80 
nmol/g of norepinephrine being the dose necessary for maximal secretion of X. laevis 
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peptides.  Injection with that dose significantly depletes the peptide stores in the skin for 
50 - 103 days, although frogs still have the capacity to secrete approximately 19,180 µg 
of peptides per milliliter in mucus.  In comparison, a moderate dose (20 nmol/g) of 
norepinephrine depletes peptides for approximately 20 days, and the frogs retain a 
capacity to secrete about 10,394 µg of peptides per milliliter in mucus.  X. laevis 
individuals that have been peptide depleted with 80 nmol/g of norepinephrine are more 
susceptible to B. dendrobatidis as measured by an increase of infection intensity on the 
skin and an increase in weight loss after exposure.  This work demonstrates the 
importance of the antimicrobial peptide defenses in the skin for protection against 
chytridiomycosis, as depletion of the peptides leads to increased susceptibility to this 
pathogen. 
 
Adaptive immune responses play an important role in resistance to B. dendrobatidis 
infection 
 
 The adaptive immune responses in X. laevis against B. dendrobatidis are largely 
unknown, and my work aims to determine whether adaptive immunity is necessary for 
resistance against B. dendrobatidis.  The prevailing view in the literature is that adaptive 
immunity does not play a significant role in the protection of amphibians from 
chytridiomycosis.  This view is based on reports that there are limited lymphocytic 
infiltrates in the skin after exposure (15, 162), and that R. muscosa juveniles immunized 
with formalin-killed B. dendrobatidis were not protected after exposure to the fungus 
(212).  However, there is no evidence that the immunization protocol induced a response 
(212).  A systematic study of adaptive immunity against B. dendrobatidis is lacking.  My 
work concludes that adaptive immunity is likely to be involved in protection of X. laevis 
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individuals from chytridiomycosis after exposure to B. dendrobatidis.  A sublethal dose 
of X-irradiation greatly impacts the number of leukocytes present in the spleen for 
adaptive responses without perturbing the skin or interfering with the ability to secrete 
peptides.  This irradiation also leads to increased infection intensity on the skin and 
greater weight loss after exposure to B. dendrobatidis.  The increased susceptibility 
suggests that an irradiation-sensitive compartment of the X. laevis adaptive immune 
system is playing a role in protecting this species from chytridiomycosis. 
 To determine whether X. laevis is capable of mounting an effective adaptive 
immune response to B. dendrobatidis, we immunized individuals intraperitoneally with 
heat-killed B. dendrobatidis and assayed the production of pathogen-specific antibodies 
in the serum.  My work suggests that individuals immunized against B. dendrobatidis 
have significantly higher levels of pathogen-specific IgM and IgY in the serum compared 
to controls.  These results demonstrate that X. laevis individuals are able to mount a 
robust adaptive antibody response to B. dendrobatidis.  Although immunization leads to a 
productive systemic response, it is unclear whether elevated antibodies in circulation 
would be protective in frogs.  We suggest that adaptive immune responses in the skin 
would be key to protection, contradicting earlier reports that suggest that adaptive 
immunity is not protective against B. dendrobatidis.  My work also evaluates a potential 
mechanism for adaptive immune protection in the skin after infection with B. 
dendrobatidis.  Frogs that were previously exposed to B. dendrobatidis have pathogen-
specific antibodies in their mucosal secretions of all three major amphibian 
immunoglobulin classes (IgM, IgY, and IgX).  These individuals also have high levels of 
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all three classes when assessing total levels of antibodies, suggesting that antibodies 
secreted onto the surface of the skin may aid in protection against chytridiomycosis. 
 Taken together, both innate and adaptive immune responses are necessary to 
protect species from chytridiomycosis after exposure to B. dendrobatidis.  Antimicrobial 
peptides secreted onto the skin would prevent the initial colonization of the skin or re-
infection after the release of newly emerging zoospores.  Adaptive responses may be 
mobilized to help control or eliminate infections that the antimicrobial peptides could not 
clear.  Thus, a deficiency in either response could increase the susceptibility to fatal B. 
dendrobatidis infections.  With this knowledge, we aimed to answer a second question 
that arose during the course of my work.  Does B. dendrobatidis possess a mechanism for 
inhibiting adaptive immune responses in infected amphibians? 
 
B. dendrobatidis modulates adaptive immunity by inducing apoptosis in lymphocytes 
 
 Some species of fungal pathogens are capable of inducing hyporesponsiveness in 
lymphocytes, especially T cells, to suppress adaptive immune responses and to gain a 
survival advantage after successful colonization (6, 13, 38, 45, 215).  In the process of 
determining the adaptive immune responses in X. laevis after immunization with B. 
dendrobatidis, we evaluated the proliferation of lymphocytes from immunized 
individuals after culture with B. dendrobatidis cells.  Lymphocytes cultured with B. 
dendrobatidis are unable to proliferate as measured by increased 
3
H-thymidine uptake.  
However, there is no inherent defect in the capability of these cells to proliferate, as 
lymphocytes from all frogs proliferate significantly when cultured with a mitogen (PHA) 
(196).  Thus, we hypothesize that B. dendrobatidis has the capacity to inhibit the 
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activation of adaptive immune responses in amphibians.  X. laevis in the wild have 
consistent prevalence of B. dendrobatidis infections since the 1940s (232), and it is 
possible that it has evolved a method of increasing its survival on the skin. 
 My work evaluates the hypothesis that B. dendrobatidis has the ability to inhibit 
amphibian lymphocytes.  Lymphocytes isolated from X. laevis and cultured with either 
heat-killed bacteria or PHA are unable to proliferate when co-cultured with B. 
dendrobatidis mature sporangia and zoospores.  This effect is dependent on the numbers 
of B. dendrobatidis cells present in the culture, and proliferation is completely abolished 
in lymphocytes at a ratio of one B. dendrobatidis cell to one lymphocyte.  Both live and 
heat-killed B. dendrobatidis cells are able to inhibit this proliferation, though live cells 
inhibited more.  Two different B. dendrobatidis isolates (JEL 197 and JEL 275) inhibit 
proliferation similarly.  These data demonstrate that B. dendrobatidis is able to prevent 
the full activation and proliferation of lymphocytes by an unknown mechanism. 
 Because both live and heat-killed fungal cells can inhibit lymphocyte 
proliferation, B. dendrobatidis might induce hyporesponsiveness by a cell contact-
dependent mechanism.  It is also possible that B. dendrobatidis could produce a secreted 
molecule that could perform this function.  My work assesses whether cell contact is 
required for B. dendrobatidis to inhibit proliferation.  When mitogen-stimulated 
lymphocytes are cultured directly with B. dendrobatidis whole cultures (both present in 
the same well), the lymphocytes are unable to proliferate.  When lymphocytes are 
physically separated by a transwell insert, B. dendrobatidis is still able to significantly 
inhibit, although at a diminished capacity.  This suggests that B. dendrobatidis releases a 
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factor that can diffuse across a transwell filter, interact with activated lymphocytes, and 
prevent their proliferation. 
 The previous work was conducted using a mixture of B. dendrobatidis mature 
sporangia and zoospores.  However, the zoospore is the infectious life stage responsible 
for establishing an infection on the surface of amphibian skin.  To what extent zoospores 
come into direct contact with cells of the immune system during an initial infection is not 
clear.  It is possible that zoospores could encounter lymphocytes within the skin and 
would be able to inhibit the proliferation of activated lymphocytes in order to increase 
their chances of entering epidermal cells to mature.  Live B. dendrobatidis zoospores can 
inhibit lymphocyte proliferation but only when they are cultured for three days in the 
presence of lymphocytes.  Heat-killed zoospores, however, are incapable of inhibiting 
lymphocytes, suggesting that live zoospores are developing into a more mature stage 
during the three days of culture, and the more mature cells are synthesizing and secreting 
the inhibitory factor.  This is supported by the failure of zoospores to inhibit proliferation 
in lymphocytes across a 0.4 µm filter in a transwell assay even when they are co-cultured 
with lymphocytes in the upper chamber of the transwell system.  These data suggest that 
maturing zoospores are able to directly inhibit lymphocytes in co-culture, but they are not 
producing the inhibitory molecule at concentrations sufficient for inhibition at a distance.  
We speculate that the inhibitory factor produced by sporangia may be part of the cell well 
present on mature B. dendrobatidis cells, as zoospores lack a cell wall (135, 162). 
 As mentioned, X. laevis has been showing steady B. dendrobatidis prevalence 
levels in the wild since the 1940s, and it is possible that the immune suppression would 
have arisen due to co-evolution between the fungus and this species.  My work aims to 
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determine whether B. dendrobatidis-specific prevention of proliferation could occur in 
another species.  Lymphocytes from R. pipiens stimulated with either heat-killed bacteria 
or PHA are unable to proliferate when co-cultured with B. dendrobatidis.  This suggests 
that the hyporesponsiveness is not species-specific.  It is possible that B. dendrobatidis 
could use this mechanism to increase its chances of survival on the skin of all amphibian 
species, allowing it to affect many amphibian populations as it spreads across the globe. 
 My work gives definitive evidence that B. dendrobatidis prevents the proliferation 
of lymphocytes, thus attenuating the adaptive immune response against it.  However, the 
mechanism by which B. dendrobatidis interferes with lymphocyte proliferation is 
unknown.  It is possible that B. dendrobatidis could induce anergy, or could signal the 
cells to undergo apoptosis.  Using flow cytometry to determine the mechanism of action, 
we find that lymphocytes cultured in the presence of B. dendrobatidis have significantly 
higher percentages of apoptotic cells over time.  This apoptosis is more pronounced in T 
cells, although a modest amount of apoptosis also occurs in B cells.  These data show that 
B. dendrobatidis induces apoptosis in lymphocytes, especially in T cells, thus interfering 
with a frog‟s ability to mount an effective adaptive immune response.  Though we see 
inhibition of B cell proliferation when lymphocytes were stimulated with heat-killed 
bacteria and cultured with B. dendrobatidis, the percentages of B cells undergoing 
apoptosis are low. 
 
Determining resistance or susceptibility to B. dendrobatidis infections 
 The results from my dissertation work hint at a complex relationship between the 
fungal pathogen B. dendrobatidis and its amphibian host.  The interplay between innate 
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and adaptive defenses in the frog to prevent infection and inhibitory responses by the 
fungus may determine whether an amphibian species is resistant or susceptible to fatal 
chytridiomycosis.  When a zoospore attempts to infect the skin of a frog, it must first 
overcome the innate defenses on the skin surface.  These defenses include antimicrobial 
peptides (53, 60, 187-191, 193, 194, 206, 234-236), lysozyme (123, 157, 243), 
metabolites produced by the resident skin bacteria that can be inhibitory to B. 
dendrobatidis growth (36, 93), and mucosal immunoglobulins (169).  If B. dendrobatidis 
can survive these initial attacks, it will establish an infection and continue to propagate.  
Over time, adaptive immune responses would be mobilized to help ward off, and 
potentially eliminate, infection.  However, B. dendrobatidis can resist by releasing a 
molecule that can kill lymphocytes via apoptosis, thus making it harder to fully eradicate. 
 There are three possible outcomes of infection with B. dendrobatidis.  In 
amphibian species that have robust antimicrobial peptides, such as X. laevis, most 
zoospores that attempt to begin an infection would be killed.  Those few that do survive 
may be able to establish a light infection (low intensity of infection), but the population 
on the skin would be too low to attenuate adaptive immunity to a significant degree.  The 
adaptive immune system will become activated and would easily control or eliminate the 
infection.  These species would be considered resistant.  In the second case, the 
antimicrobial peptide defenses are very weak, and the invading zoospores would be able 
to quickly establish a heavy infection (high intensity of infection).  Growing unchecked 
on the skin, a large amount of the inhibitory molecule would be produced, preventing the 
adaptive immune system from activating.  The infection intensity on the skin would 
eventually reach critical levels, and the infected frog would die due to the disruption of 
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the skin‟s normal function, leading to cardiac arrest.  These species would be considered 
highly susceptible.  The third outcome is largely dependent on whether or not individual 
antimicrobial peptide responses are effective.  A study in R. pipiens shows that 
geographically distinct populations had differing peptide effectiveness against B. 
dendrobatidis (218).  In this sense, it would be possible for certain individuals in a 
population to be susceptible (weak peptide effectiveness) while others are resistant 
(strong peptide effectiveness), and the same could be true for different populations of the 
same species.  These species would be considered moderately susceptible. 
 The work contained within this dissertation highlights the importance of both 
innate immunity, especially antimicrobial peptides, and adaptive immune responses in the 
protection of amphibian species resistant to B. dendrobatidis.  By understanding the role 
both play, researchers may be able to devise ways to protect susceptible frog species in 
the laboratory before releasing them back into the wild.  Methods to increase peptide 
effectiveness or strengthen adaptive responses in the skin may be considered.  It is hoped 
that this research will help aid conservation efforts to protect these very valuable 
members of our ecosystem. 
 
Future Directions 
 Although this dissertation presents significant new information about innate and 
adaptive immune responses in amphibians against B. dendrobatidis, much work remains 
in order to fully understand the involvement of both systems.  Some key questions remain 
to be answered for antimicrobial peptide defenses, adaptive immunity, and B. 
dendrobatidis-induced lymphocyte hyporesponsiveness. 
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 Current work in the Rollins-Smith laboratory is underway to determine the 
effectiveness of one injection of the maximal dose of norepinephrine in fully depleting 
peptide stores in the skin of amphibians.  Work completed by Scott Fites and Whitney 
Gammill, which is in concordance with work presented in this dissertation, suggests that 
after one injection with 80 nmol/g of norepinephrine, X. laevis still possesses some 
capacity to secrete antimicrobial peptides.  Histology of skin from frogs injected once 
show that, although most of the granular glands are empty, many still contain secretory 
granules.  This may explain why a peptide depletion experiment in larger frogs failed to 
show any increased susceptibility in X. laevis to B. dendrobatidis.  However, two 
injections with 80 nmol/g of norepinephrine in three days left virtually all of the granular 
glands empty.  A third injection did not lead to any significant peptide release, suggesting 
that two injections leads to full depletion of antimicrobial peptide stores.  It would be of 
interest to repeat the peptide depletion studies in X. laevis after two injections of the 
maximal dose of norepinephrine.  It is expected that these frogs would have higher 
intensities of infection on the skin after exposure to B. dendrobatidis, as well as more 
consistent infections. 
 Because immunoglobulins are present in mucosal secretions, injecting frogs with 
norepinephrine when depleting the skin of its peptides may also reduce the amount of 
antibodies available in the mucus.  Future studies are needed to determine whether 
norepinephrine injections also deplete the frog‟s skin of its immunoglobulin reserves.  
The concentration of antibodies present in mucosal secretions would be compared 
between frogs that had been injected only once and frogs that had been injected a second 
time within three days.  If it is found that antibodies are also depleted, the kinetics of 
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antibody renewal will be investigated as frogs are re-injected at various time points after 
the initial induction.  Immunohistochemistry could also be performed to show that 
antibodies are present in the skin, and whether the levels of antibodies are reduced after 
norepinephine injection. 
 Irradiation of X. laevis with a sublethal dose of X-rays increases susceptibility to 
B. dendrobatidis after exposure.  Although it can be concluded that an irradiation-
sensitive compartment of adaptive immunity plays a role in resistance, the identity of this 
compartment is not known.  It would be beneficial to determine whether B cell responses 
or T cell responses, or both, are necessary for resistance to chytridiomycosis.  X. laevis 
individuals could be injected with reagents directed against B cells or T cells to deplete 
those cell subsets in vivo.  Infection intensities and weight losses would be measured over 
time in control (untreated), B cell depleted, T cell depleted, or doubly depleted frogs after 
exposure to test which compartment plays a role in resistance to B. dendrobatidis.  Also, 
X. laevis tadpoles can be thymectomized to rear T-cell deficient frogs (71, 89, 105, 178, 
219), and their susceptibility to B. dendrobatidis can also be measured.  It is expected that 
one or both of these compartments would be responsible for protection of frogs from 
chytridiomycosis.   
 The work presented in this dissertation is the first to identify the presence of 
mucosal antibodies in amphibians.  However, it is not known if the immunoglobulins in 
the mucus play a role in protecting frogs from chytridiomycosis.  First, experiments to 
determine whether mucosal antibody concentrations can be significantly increased in the 
skin after exposure to B. dendrobatidis should be conducted.  Frogs would be 
experimentally infected with the fungus, and a subset of frogs would be induced to 
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secrete mucosal antibodies by norepinephrine injection at various time points after 
exposure.  It is possible that the concentration of mucosal antibodies would increase after 
exposure to B. dendrobatidis.  Second, whether the antibodies are functionally protective 
would need to be evaluated.  Mucosal secretions containing antibodies would be tested 
for their ability to inhibit B. dendrobatidis growth in vitro by complement-mediated 
destruction.  If the antibodies are protective, they should be able to inhibit B. 
dendrobatidis growth. 
 Due to lack of reagents in amphibian species other than X. laevis, it is very 
difficult to determine whether an effective adaptive immune response is being generated 
in other species either after experimental exposure or immunization to B. dendrobatidis.  
By developing reagents to B cells, T cells, and all three immunoglobulin classes, it would 
be possible to expand the research presented in this dissertation to other species of 
amphibians.  This is especially important when testing whether immunization of a 
susceptible species would increase resistance to B. dendrobatidis infection.  If 
immunization fails to protect, it would be possible to evaluate whether an adaptive 
immune response was even generated in the immunized individuals.  Though there is a 
possibility to use alternate methods to demonstrate activated adaptive immune responses 
in other species, such as the antibody-mediated growth inhibition assay, using specific 
reagents would be more reliable. 
 B. dendrobatidis has the capability of inhibiting the proliferation of activated 
lymphocytes by inducing apoptosis in these cells.  Evidence presented in this dissertation 
suggests that the molecule is released by B. dendrobatidis.  Further characterization of 
the molecule in question needs to be performed in order to determine what type of 
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molecule it is.  Experiments to determine if it is stable in heat, affected by acid, or 
susceptible to proteases are currently under way.  Once the characterization of the 
molecule is concluded, research can be undertaken to identify the factor.  Once identified, 
it would be of interest to determine whether the B. dendrobatidis factor can be inhibited 
or manipulated experimentally to produce a less virulent isolate of the fungus for 
vaccination studies. 
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